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Abstract
The delivery of nucleic acids has the potential to revolutionize medicine by allowing
previously untreatable diseases to be clinically addressed. Viral delivery systems have
been held back by immunogenicity and toxicity concerns, but synthetic vectors have
lagged in transfection efficiency. This thesis describes the rational design and systematic
study of three classes of bioresponsive polymers for nucleic acid delivery. A central
theme of the study was understanding how the structure of the polymers impacted each of
the intracellular steps of delivery, rather than solely the end result. A powerful tool for
efficiently quantifying endosomal escape was developed and applied to each of the
material systems described. First, a linear-dendritic poly(amido amine) -poly(ethylene
glycol) (PAMAM-PEG) block copolymer system previously developed in our lab was
evaluated and its ability to overcome the sequential barriers of uptake, endosomal escape,
and nuclear import were characterized. Next, a class of crosslinked linear
polyethyleimine (xLPEI) hyperbranched polymers, which can contain disulfide-
responsive linkages, were synthesized and investigated. It was demonstrated that free
polymer in solution, not the presence of a functional bioresponsive domain, was
responsible for the highly efficient and relatively nontoxic DNA delivery of this
promising class of crosslinked polyamines. Finally, this analysis was applied to siRNA
delivery by a library of amine-functionalized synthetic polypeptides. The pH-responsive
secondary structure, micelle formation, and ester hydrolysis were studied prior to the
discrete barrier-oriented analysis of the siRNA delivery potential of this library. It is
hoped that the tools, materials, and systemic analysis of structure-function relationships
in this thesis will enhance the process of discovery and development of clinically relevant
gene carriers.
Thesis Supervisor: Paula T. Hammond
Bayer Professor of Chemical Engineering
Thesis Supervisor: Robert S. Langer
Institute Professor
Chapter 1. Background
1.1 The Promise of Gene Therapy
Many diseases for which there is current unmet medical need could potentially be treated
with nucleic acid therapies [1]. Gene expression introduced in target tissues could
replace defective genes that result from inherited or acquired disease. Though
revolutionary, gene therapy has not yet been successful clinically due to the difficulty of
delivering DNA into nuclei of cells which require it [2].
1.2 Gene Delivery Vectors
The major classes of vectors capable of transfection are presented in this section,
including modified viruses, cationic lipids, and cationic polymers.
1.2.1 Viruses
A successful gene delivery vehicle must evade the immune system and efficiently deliver
its nucleic acid payload into the nuclei of target cells for transcription. Nature already has
developed such a structure: the virus. It is possible to insert desired recombinant DNA
into a viral construct and achieve transfection [3]. Currently, the most popular viral
vectors are retroviruses and adenoviruses, due to their ability to infect a wide variety of
cell types, efficient gene transfer, and relatively long research history [4-6]. However,
viral vectors are unlikely to have long-term clinical impact due to concerns of genome
insertion and immunotoxicity [7, 8]. The need for viable alternatives is underscored by
the fact that viral vectors are still the overwhelming choice of vector in clinical trials [9].
1.2.2 Cationic Lipids
Cationic lipids were first demonstrated as highly effective transfection agents by Felger,
et. al in 1987 using DOTMA (dioleyloxypropyltrimethylammonium) [10]. It is believed
that the lipid-DNA complexes are taken into the cell via endocytosis and then released
from the endosome due to the lipid's membrane disruption properties [11]. Though
LipofectamineTM was much more efficient than previous non-viral delivery vehicles,
toxicity remains a concern, as membrane disruption can be harmful as well as helpful
[12].
1.2.3 Cationic Polymers
Cationic polymers have the potential to be safe, effective DNA carriers [13-15]. Positive
charge condenses and complexes with negatively-charged DNA [16]. Many polymers
such as polyethyleneimine (PEI) have amine groups which can be protonated in order to
achieve endosomal escape via the proton sponge effect (see 1.3.1). PEI is widely used
and is considered one of the most efficient commercial polymers for transfection [16, 17].
It is synthesized in either linear or branched forms and transfection efficiency is quite
sensitive both branching and molecular weight [18, 19]. Toxicity is one drawback to PEI
if not modified with polyethylene glycol (PEG) [20, 21]. Furthermore, PEI is still far less
efficient than viral vectors, limiting its clinical utility. Other cationic polymers used in
gene delivery such as poly-L-lysine [22], chitosan [23], polyorthoesters [24], poly-p-
aminoesters [25, 26], and dendritic polymers(discussed separately in the following
section) also generally suffer from low transfection efficiency but remain relatively non-
toxic.
1.2.4 Dendrimer-based Vectors
Dendrimers are branched polymers with a hierarchically ordered, tree-like structure [27].
Dendrimers are thus multivalent and can express functional groups or charges in great
concentration at higher generations. Cationic dendrimers have found utility in gene
delivery applications due to their high charge density and buffering potential of interior
amines [28, 29]. In an initial success, Haensler and Szoka showed that negatively charged
polyamidoamine (PAMAM) could be used to transfect a variety of cell lines [28].
Haensler and Szoka used so-called starburst, or cascade, dendrimers, which consist of a
dense network of internal tertiary amine groups. These amine groups are helpful
facilitating endosomal escape via the proton sponge effect (see 1.3.1). A counterintuitive
result that followed indicated that partially degraded PAMAM dendrimers showed up to a
fifty fold increase in transfection efficiency relative to intact PAMAM [30]. It is
theorized that this is due to increased conformational flexibility, though the precise cell-
vector interactions have not been thoroughly studied. PAMAM dendrimers were also
used to effectively halt tumor growth in mice by delivering anti-angiogenesis genes [31].
Like other polycationic polymers, dendrimers complex with DNA by charge association.
Transfection efficiency has been shown to be highly sensitive to small changes in the
ratio of primary amines to DNA [32]. Additionally, dendrimer generation has also been
shown to have a strong influence on both efficiency and toxicity [33]. Kukowska-Latallo
et. al. report an increase over several orders of magnitude in transfection efficiency
through 10 generations [33]. While certain modifications can greatly increase transfection
efficiency, dendrimers are still inefficient in comparison with viral vectors [34].
Furthermore, cytotoxicity of dendrimers has been studied and is non-trivial [35].
Modification with hydrophilic coatings has been shown to decrease the cytotoxicity of
the otherwise toxic cationic dendrimers, but at the expense of transfection efficiency [12,
35]. Our laboratory has previously conjugated PEG to PAMAM to reduce cytotoxicity
and the binding of serum proteins in accordance with previously reported properties of
PEG [36, 37]. With further functionalization and optimization, novel structures can be
designed using PEG and PAMAM to create vectors that will be both relatively non-toxic
and highly efficient.
1.3 Barriers to Effective Gene Delivery
Rational design of safe, effective gene delivery vectors hinges on a proper understanding
of the physiological obstacles before the vector reaches the cell and the subcellular
barriers encountered thereafter. The most important intracellular barriers to successful
transfection are presented in Figure 1.1.
DNA
polycation
Figure 1.1 Barriers to Intracellular Gene Delivery
DNA is condensed with polycations into ordered structures such as spheroids. These
condensates interact with the cell membrane and are endocytosed. Such polycations as
PEI destabilize the endosome by the "proton sponge effect" resulting in escape of the
polyplex from the endosome. The polyplex is subsequently translocated into the nucleus,
followed by decondensation and separation of the DNA from the polycationic delivery
vehicle, either outside or inside the nuclear membrane. The released DNA subsequently
undergoes transcription and translation giving rise to the protein product [38].
1.3.1 Intracellular Barriers to Gene Delivery
Once the polyplex has reached the target cell of interest, it must be internalized.
Internalization can happen via a variety of mechanisms, summarized in Figure 1.2 and
well reviewed here [39]. Polymer-based gene delivery vehicles such as PEI and PAMAM
make use of both the clathrin-mediated and caveolae-dependent pathways, though some
dependence on cell type has been noted [40-42].
Figure 1.2 Mechanisms of Internalization
Polyplexes may internalized by a variety of pathways involving various aspects of
cellular machinery. [39]
After internalization, the polyplex is enclosed in an endosome, from which it must
escape to evade degradation. Endosomal escape can be achieved by membrane disrupting
peptides [43, 44], small molecule agents such as chloroquine [45], the amphiphilic nature
of lipid gene carriers, or the so-called proton sponge effect [46, 47]. The proton sponge
effect describes the ability of amine groups on cationic polymers to buffer the endosomal
environment by becoming protonated, and is described in Figure 1.3. Protons are
continuously pumped into the endosome, leading to an excess of chloride counterions
which causes membrane rupture due to osmotic flow of water into the endosome.
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buffering activity in this p11 range. As shown in panel C, this leads to an increase in
endosomal size which ultimately leads to rupture [49].
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Figure 1.4 Effect of Polymer Buffering on Endosomal Escape
Polyamidoamine dendrimers (PAM), PEI, and Poly-L-Lysine (POL) polyplexes were
added to cells along with probes allowing for the measurement of endosomal chloride
content (A) and pH (B). Endosomal volume (C) was tracked via microscopy [49].
Once released from the endosome, the plasmid DNA must avoid degradation by
nucleases present in the cytosol [50]. For many systems, it can be unclear when the DNA
and polymer actually dissociate, but if unpacking has happened prior to the DNA
reaching the nucleus, nuclease degradation is an issue. If DNA binding is too tight,
transport through the cytosol to the nucleus can be quite difficult because the polyplex
must translocate in a dense cellular protein environment [51]. In 1984, Kalderon et. al
demonstrated that a sequence of amino acids served as a nuclear localization signal
(NLS) that promoted entry into the nucleus for proteins too large to normally penetrate
the nuclear pore complex (NPC) via a class of endogenous proteins known as importins
[52]. Conjugation of an NLS to the polymer or plasmid DNA directly has been
somewhat effective in increasing transfection activity [53-6 1]. Figure 1.5 outlines several
strategies for attaching NLS sequences to polymers, including covalent attachment,
attraction by a DNA-targeting sequence (DTS), attachment of an NLS using a peptide
nucleic acid (PNA) clamp, and simple electrostatic association of the often cationic NLS
[62]. Other strategies that have been employed involve small molecule glucocorticoids,
such as dexamethasone, to bind receptors on the nuclear envelope [63].
NIS-PNA
ndogenous
Transcription
Factors
Covalently attached
NLS peptides
Eletrostatic binding of NLS peptides
Figure 1.5 Strategies for Enhancing Nuclear Import of DNA
Several methods for attracting importins for active uptake of DNA through the nuclear
pore complex are shown [62].
1.3.2 Extracellular Barriers to Gene Delivery
DNA will be degraded by serum nucleases unless shielded by some type of physical
vector, such as a polymer [64]. Serum proteins can also non-specifically bind to
polyplexes and cause particle aggregation, which will cause polyplexes to be cleared
from the blood stream, or become trapped in fine capillary beds [65]. Additionally, the
immune system can bind opsonizing proteins to the vector surface, which leads to
immune clearance [66]. However, it has been shown that coating a vector with PEG will
significantly reduce binding of serum proteins, though at the expense of transfection
efficiency [36]. Furthermore, cell membranes carry a negative surface charge, and as
such, will non-specifically uptake positively charged polyplexes [67]. The approach
many have taken to address both non-specific uptake and transfection loss with
PEGylation is to attach a cell-specific targeting ligand to the surface of the polyplex such
as an antibody or a small molecule (e.g. folate or mannose) for which the target cell has a
receptor [68-71].
1.3.3 Analysis of Barrier Evasion Properties
Detailed analysis of the specific barriers which hinder gene delivery is crucial for the
rational design of efficient carriers. Varga et. al. used quantitative PCR to compare the
intracellular rate-limiting steps for the most popular commercial vectors in rapidly
dividing hepatoblastoma cells (C3A) [19]. It is difficult however, to draw conclusions
about the rate-limiting step in cells such as dendritic cells or macrophages which are not
rapidly dividing as hepatoblastoma cells are, and thus would have more intact nuclear
envelopes [34]. Subcellular DNA can also be tracked using confocal fluorescence
microscopy, which can quantitate location of DNA in various locations as well as
determine its complexation state [72-74]. These techniques have been used to compare
the relative efficiencies of adenovirus and Lipofectamine, with the interesting result that
the strength of the adenovirus was a four order-of-magnitude increase in protein
generated by plasmids which had already made it inside the nucleus [75]. This type of
mechanistic insight is critical and suggests a need for biodegradable vectors, improved
plasmid design, and an emphasis on understanding more about individual barriers to
transfection.
1.3.4 Effects of Free Polymer
In addition to understanding how polyplexes are interacting with the various barriers to
delivery, it is critical to understand the details of these interactions. The role of free
polymer, excess polymer that is unbound to the polyplex, has been explored in very few
studies, though its role has been shown to be critical for transfection [76-78]. Figure 1.6A
shows the purification of free branched PEI 25k from a standard preparation of PEI
polyplexes at an N/P ratio of 10. Multiple studies have estimated the fraction of PEI
actually binding DNA to correspond to approximately an N/P of 3, indicating that 70% of
the PEI is free in solution [76, 77]. As demonstrated in Figure 1.6B, when this free
polymer is removed, transfection is reduced by over an order of magnitude. However,
when this polymer is re-introduced, even several hours after initial treatment, transfection
efficiency is recovered. Thus, it is clear that polymer gene delivery vehicles exist not as a
homogenous solution but as two independent components - polyplexes and free polymer,
each of which play an important role in transfection.
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Figure 1.6 Effects of Free Polymer on Transfection
(A) Size exclusion chromatography (SEC) purification of a preparation of bPEI 25k
polyplexes prepared at N/P = 10. (B) Transfection efficiency of N/P 10 bPEI polyplexes
as assembled (N), after removal of free bPEI (P), purified polyplexes supplemented with
an equal amount of free PEI which was added either immediately upon polyplex
treatment (P+free), 1 hr after, or 4h after [76].
1.4 Thesis Overview
The complexity of the gene delivery problem necessitates a systematic and thorough
approach to engineering solutions. In particular, consideration of structure-function
relationships regarding not only overall transfection efficiency but also the discrete
barriers to delivery is crucial. In this work, we apply the concept of systematic barrier
evaluation to nucleic acid delivery systems containing bioresponsive domains designed to
effectively address multiple barriers. Chapter 2 describes the evaluation a linear-dendritic
PAMAM-PEG block copolymer system previously developed in our lab. A method for
quantifying endosomal escape in high-throughput is introduced and the merits of the
system relative to uptake, endosomal escape, and nuclear import are discussed. Chapter 3
introduces a class of crosslinked linear PEI hyperbranched polymers which can contain
disulfide-responsive linkages. The role of the disulfide bond in the efficiency and
cytotoxicity of this class of polymers is studied and the role of unbound free polymer
relative to internalization and endosomal escape is clarified. Chapter 4 demonstrates the
applicability of this analysis to siRNA delivery, in this case to a library of amine-
functionalized synthetic polypeptides. The pH-responsive secondary structure, micelle
formation, and ester hydrolysis are discussed prior to the discrete barrier-oriented
analysis of the siRNA delivery potential of this library.
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Chapter 2. Intracellular Trafficking of Polyamidoamine -
Polyethylene Glycol Block Copolymers in DNA Delivery
1.1 Abstract
The delivery of nucleic acids has the potential to revolutionize medicine by
allowing previously untreatable diseases to be clinically addressed. Viral delivery
systems have shown immunogenicity and toxicity dangers, but synthetic vectors have
lagged in transfection efficiency. Previously, we have developed a modular, linear-
dendritic block copolymer architecture with high gene transfection efficiency compared
to commercial standards. This rationally designed system makes use of a cationic
dendritic block to condense the anionic DNA and forms complexes with favorable
endosomal escape properties. The linear block provides biocompatibility, protection from
serum proteins, and can be functionalized with a targeting ligand. In this work, we
quantitate performance of this system with respect to intracellular barriers to gene
delivery using both high-throughput and traditional approaches. An image-based, high
throughput assay for endosomal escape is described and applied to the block copolymer
system. Nuclear entry is demonstrated to be the most significant barrier to more efficient
delivery and will be addressed in future versions of the system.
1.2 Introduction
Nucleic acid therapies have unique potential as a transformative element in
clinical medicine over the coming decades. The primary barrier to clinical application of
gene therapy has been the lack of safe, efficient materials to deliver genes to appropriate
tissues [1, 2]. A variety of viral vectors, including adenoviruses, adeno-associated viruses
(AAVs), and retroviruses have been studied as gene delivery agents [3]. While these
materials can achieve high levels of protein expression, they have suffered from concerns
of safety, immunogenicity, scale-up for manufacturing, and limited size of the delivered
gene [1]. When viral vectors are used for transient gene expression, the increased
immune response upon repeat injections becomes a limiting factor [4, 5].
Synthetic systems have been developed as a safer alternative to viral transfection,
but have struggled to achieve efficiency (protein produced per plasmid) on the same
order of magnitude as viral vectors. Synthetic delivery systems include cationic polymers
[6, 7], liposomes [8-10], and dendrimers [11, 12], among other material classes.
Polymeric systems developed include linear and branched polyethyleneimine (PEI) [13],
linear and dendritic polyamidoamine (PAMAM) [11], poly-p-amino esters (PBAE) [14-
16], as well as many other linear and branched polyamines [17]. The molecular design of
such polymeric systems must overcome several extracellular and intracellular barriers to
achieve therapeutic levels of protein expression. In the bloodstream, DNA complexes
must avoid hepatic and renal clearance, detection and removal by the immune system,
binding to charged serum proteins, inter-complex aggregation, degradation by plasma
nucleases and uptake by non-targeted somatic cells [18-21]. Complexes then must be
taken up efficiently by the cells of interest, and escape the endosomal compartment into
which they are initially trafficked. Failure to do so results in degradation in the lysosome,
recycling to the cell membrane, and lack of transfection. Once out of the endosome, the
complex must translocate to the nucleus and cross the nuclear membrane . Unpackaging
of the DNA from the complex is also necessary prior to expression of the delivered
plasmid by the host cell. As synthetic vectors do not contain transcription factors as
viruses do, the final expression of uncomplexed plasmids in the nucleus has been shown
to be a bottleneck as well [22].
In order to address these barriers to transfection, our lab has previously developed
a linear-dendritic block-copolymer system, in which a generation 5.0 PAMAM dendron
is conjugated to a polyethylene glycol (PEG) linear block, which itself is end-linked to a
targeting moiety [23, 24]. This PAMAM-G5-PEG system performed well in vitro, with
transfection efficiencies nearly ten-fold greater than commercially available branched
PEI, and it displayed targeted, receptor-mediated uptake with cytotoxicities significantly
lower than unmodified PAMAM or PEI. The targeting moiety on the targeted PAMAM-
G5-PEG conjugates is a short peptide, WIFPWIQL, identified from in vivo phage display
techniques by the Arap/Pasqualini lab [25]. WIFPWIQL binds GRP78/BiP/HSP70 - a
glucose-response protein found intracellularly at the endoplasmic reticulum (ER) in
benign cell types, but on the cell membrane of many solid tumor cell types [26, 27]. In
our previous publication, we reported on the synthesis, DNA complexation, and overall
in vitro transfection efficiency of these conjugates. In this work, we characterize the
intracellular trafficking of this system in order to identify the bottlenecks to more
efficient delivery with these synthetic vectors, and further elucidate the mechanisms
which enable any enhanced efficiency of this system over other common polyamines. We
also introduce a new method for high-throughput screening of the endosomal escape
properties of various polyplex formulations.
1.3 Materials and Methods
1.3.1 Materials
Generation 5.0 cystamine core PAMAM dendrimers were obtained from
Dendritic Nanotechnologies (Mount Pleasant, MI) and used without further purification.
Heterobifunctional poly (ethylene glycol) (Maleimide-PEG5k- N-hydroxysuccinimide)
was obtained from Laysan Bio (Arab,AL). WIFPWIQL peptide was synthesized and
purified by the MIT Biopolymers lab in the Swanson Core facilities at the Koch Institute.
Immobilized Tris(2-carboxyethyl)phosphine (TCEP) reducing gel was obtained from
Pierce (Thermo Fisher Scientific, Rockford, IL). Branched 25,000 g/mol (M,)
polyethyleneimine (PEI) and other chemical reagents were purchased from Sigma
Aldrich (St. Louis, MO). DU145 cells and cell culture media were obtained from ATCC
(Manassas, VA). pCMV-EGFP-N1 plasmid DNA was obtained from Aldevron
Inc.(Fargo, ND). All other cell culture reagents were obtained from Invitrogen (Carlsbad,
CA).
1.3.2 Block Copolymer Synthesis
PAMAM-G5-PEG block copolymers were prepared in a three-step synthesis. In
the first step, generation 5.0 cystamine core PAMAM dendrimer (60.0 mg, 2.05 pmol)
was reduced using immobilized TCEP gel (1.5 mL) for 90 min. Confirmation of the
reduction was done using (5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, Ellman's reagent)
to quantify free thiols and fluorescamine to quantify primary amines. Reduction was
greater than 80%. In parallel, targeting peptide WIFPWIQL (7.1 mg, 6.5 pmol) was
dissolved in DMSO at 5 mg/mL and added to a solution of Mal-PEG5k-NHS (30 mg, 5.4
pmol) in DMSO at 5 mg/mL. 20 pL triethylamine (TEA) was added to facilitate the
reaction. After 30 min, this reaction was twice precipitated in cold ether, dissolved in
PBS and reacted with the reduced PAMAM dendrimer for 24 hours. Untargeted polymers
were synthesized by substituting monofunctional MAL-mPEG5k for the WIFPWIQL-
PEG-MAL. The synthesized polymers were dialyzed against 8000 MWCO SpectraPOR
(Spectrum Labs, Rancho Dominguez, CA) and lyophilized. Structure was confirmed by
'H-NMR (400MHz, D20) 6 (ppm) = 3.69 (s, CH2CH20), 3.48 (t, CONHCH 2CH 2NH2),
3.30 (t, CONHCH 2CH 2NR), 3.11 (t, CONHCH 2CH2NH 2), 2.85 (m, NCH 2CH 2CONH),
2.64 (t, CONHCH 2CH 2NR), 2.45 (m, NCH2CH 2CONH)
1.3.3 Cell Culture
DU145 cells were cultured in Minimum Essential Media (MEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin in a
humidified 37*C atmosphere at 5% CO2.
1.3.4 Transfection
Cells were trypsinized prior to transfection and seeded in 96-well plates at 5,000
cells/well overnight in a humidified 37'C atmosphere at 5% CO 2. PAMAM-PEG block
copolymers were diluted in 25 mM sodium acetate buffer (NaAc) (pH 5.5) at 1.5 mg/mL
initially and then further diluted into 25 gL of the same buffer in a separate 96-well plate
at varying concentrations. 25 pL of pDNA at 0.06 mg/mL in NaAc was then added to
each well and mixed by gentle pipetting. After 10 min for complex formation, 30 gL of
the complexes were added to 200 pL of Opti-MEM supplemented with 10% FBS. After
further mixing, 150 gL of the complexes in Opti-MEM were added to the cells (after
growth media had been removed). After 4 hours, the complexes in Opti-MEM were
removed and growth media was added. Cells were assayed at 48 hr for GFP production
using flow cytometry. 4000 - 10000 live cells per sample were analyzed. GFP production
was normalized to that from transfection with an optimized formulation of 25kDa
branched PEI [28]. p-values were calculated using a two-way analysis of variation and
Bonferroni post-tests were performed on all conditions shown.
1.3.5 Flow Cytometry
Flow cytometry was performed in U-bottom 96-well plates using an LSR II HTS
Flow cytometer (Becton-Dickinson, Mountain View, CA). To prepare samples, media
was removed from cells and replaced with 25 gL trypsin for 5 minutes. 50 pL of PBS
supplemented with 2% FBS was then added to each well, mixed, and the entire 75 gL cell
suspension transferred into a U-bottom 96-well plate.
1.3.6 Polyplex Uptake
Block copolymers and PEI were labeled with fluorescein isothiocyanate (FITC) at
a molar ratio of 4:1 (dye:polymer). Using the labeled polymers, polyplexes were formed
and cells treated as described in the above section. At the time indicated, cells were
removed from the incubator and analyzed using flow cytometry. p-values were calculated
using a two-way analysis of variation and Bonferroni post-tests were performed on all
conditions shown.
1.3.7 High-Throughput Endosomal Escape
Complexes were assembled and transfection was conducted as described above,
except that 25 gM calcein was added to the Opti-MEM and cells were seeded in black-
sided, clear-bottom 96-well plates. 4 hours after transfection, 5 ptL of a solution of
Hoechst 33342 diluted to 1:30 in PBS was added. After 20 minutes of staining,
complexes and free dye were removed, and the cells were washed 3 times with PBS. 150
pL of phenol-free Opti-MEM with 10% serum was added to each well before the plate
was covered with an opaque sticker, foiled, and analyzed. Imaging was done using a
Cellomics ArrayScan VTI HCS Reader (Thermo Fisher, Waltham, MA) and analysis was
done using the included software as described below. 300 - 3000 live cells per sample
were analyzed. p-values were calculated using an unpaired t-test.
20 fields per well were imaged with a 20x objective, yielding 300 - 3000 cells.
Autofocus was used for each field, based on the nuclear (Hoechst) channel with no Z-
Offset. Exposure time was fixed at 0.15 s. Objects (nuclei) were identified using the
Isodata thresholding method and considered single cell nuclei if the object area was
between 40 and 400 square pixels. After the nuclei were identified, the cytoplasmic area
was defined as being a ring a fixed distance outside the nucleus. After defining "escaped"
and "non-escaped" cells, the most accurate combination of parameters for separating the
two was based on the average calcein channel intensity in the central nuclear region.
Since the majority of the cytoplasmic volume appeared to be present outside this region,
calcein-filled endosomes rarely existed in this region. However, in escaped cells, the
cytoplasmic region above & below the nucleus, even with relatively low volume, would
always have some calcein signal. A threshold in this value was empirically set and could
vary based on camera type, light source, and exposure time. Methods defining the
number of cytoplasmic spots and their intensity relative to the rest of the cytoplasm were
ultimately inferior to this method. Future iterations of this assay may determine degree of
escape or identify cells with both diffuse and punctuate calcein staining. Finally, note the
images shown in Figure 3 are intensity normalized in order to better visualize the
punctate staining pattern - all calculations are done with unstreched images (and thus the
apparently different level of background in Figure 3 is not a problem).
1.3.8 Confocal Microscopy
8-well Lab-Tek chamber slides (Thermo Fisher, Waltham, MA) were treated for
20 minutes with human fibronectin in PBS at 0.01 mg/mL. The fibronectin was removed
and DU145 cells were trypsinized and seeded in each well at a concentration of 1000
cells/well 24 h before transfection. Plasmid DNA was labeled with Rhodamine-CX using
the Label-IT kit (Mirus Bio, Madison, WI). Polymers were FITC-labeled as described
earlier. Polyplexes between labeled DNA and labeled polymers were formed in NaAc
buffer as described earlier. 40 pL of complexes were added to 160 uL phenol-free Opti-
MEM (supplemented with 10% serum) and added to each well. Complexes were
removed after 4 h and replaced with growth media. At 24 h, cells were fixed with 3.7%
formaldehyde in PBS, stained with Hoechst 33342, and were washed 3 times with PBS.
Imaging was done on a PerkinElmer Ultraview spinning disc confocal (PerkinElmer,
Waltham, MA).
1.4 Results and Discussion
1.4.1 Synthesis
Synthesis of the PAMAM-G5-PEG linear-dendritic block copolymers was similar to that
reported previously by our group [24] and is shown in Scheme 2.1. Briefly, generation
5.0, cystamine core dendrimers were first reduced to expose dendrons with a single thiol
moiety (yielding two dendron-thiols per dendrimer) . In parallel, the N-
hydroxysuccinimide (NHS) group of a heterobifunctional PEG was first reacted with the
terminal lysine on the WIFPWIQL peptide, leaving the maleimide group of the PEG
block free for subsequent conjugation to the exposed thiol on the reduced PAMAM
dendrimer. This synthetic approach is managed easily in aqueous solutions and can be
generally applied to most targeting ligands.
WIFPWIQL-NH 2 +
Targeting Peptide
ss
G5 PAMAM Dendrimer
Cystamine Core
0 0
O O0
Heterobifunctional
Poly(ethylene glycol)
Immobilized
TCEP gel
PBS
10mM EDTA
90 min
H0
TE o WIFPWIQL'N
DMNSO 0
30 min
PBS
16h
Scheme 2.1 Synthesis of PAMAM-G5-PEG-WIFP conjugates.
The targeting peptide is first reacted with a bifunctional linker before being precipitated
and added to reduced G5 PAMAM dendrimer.
1.4.2 Overall Transfection
While the overall transfection efficiency of a gene carrier is a critical parameter to
characterize, it is ultimately necessary to determine the bottlenecks - quantitatively if
possible - in order to better design future iterations of the system. As shown in Figure
2.1A, the targeted block copolymers transfected DU145 cells nearly 8-fold better than
25kDa bPEI and nearly 4-fold better than an untargeted control block copolymer, which
is consistent with our previously published studies using this system [24]. Figure 2.1B
show that the presence of serum in the system limited the absolute percentage of cells
transfected to a less than 3% and the fold increase of targeted block copolymer was 3-
fold over both the untargeted control and PEI. While PEI is an efficient gene carrier in
serum-free media, in more biologically relevant conditions (i.e. 10% or more serum), the
advantage of the PEGylation in the block copolymer system becomes apparent [29].
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Figure 2.1 Normalized transfection efficiency (A) and percentage of cells transfected
(B) of targeted and untargeted block copolymer formulations at various
polymer:DNA ratios.
Transfections of EGFP were performed in 10% serum and analyzed 48 hrs later using
flow cytometry. An optimized formulation of PEI at a polymer:DNA ratio of 2:1 was
used and data is reported as mean fluorescence intensity normalized to that of the PEI
transfected cells. Error bars represent SEM of 5 replicate experiments (*** = p < 0.001,
** = p < 0.01, * = p < 0.05, ns = not significant). These results are in agreement with
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previously published reports of transfection efficiency of this block copolymer system
(26).
1.4.3 Uptake
Once in the immediate vicinity of the target cell, the polyplex must first undergo
binding and internalization. While it is possible to characterize many aspects of the
binding and internalization process [30], at this time we chose to simply focus on the
degree of polyplex association with the target cells. In this study, each polymer system
was labeled with a fluorophore (FITC) and the labeled polyplexes were added to DU145
cells. Figure 2.2 shows the median cell associated fluorescence achieved by the various
delivery vehicles after 1-4 hrs of incubation, as measured by flow cytometry. Intracellular
uptake of the PAMAM-G5-PEG WIFP block copolymer complexes exhibit a 12-fold
increased cellular uptake over PEI; the untargeted PAMAM-G5-PEG also yielded a 5-
fold gain versus the PEI control. This is consistent with other reports that the PEG
exterior shell generated in the block copolymer polyplexes gives a significant advantage
in shielding them from adsorption of proteins [31]. The presence of serum proteins
(particularly albumin) can abrogate the uptake of PEI by binding PEI complexes prior to
cell uptake [29]. Of note is that the general relationship between the uptake efficiencies
and overall transfection efficiencies of these polymers is similar, implying that at least
one principal difference between their effectiveness is their differential uptake ability.
However, the fold increases in the percentage of transfected cells of the block copolymers
over PEI are much less than the fold increases in uptake, suggesting that PEI may be
more effective at mediating downstream events. Another difference could lie in the
endosomal trafficking of polyplexes internalized via GRP78 binding [32] versus those
internalized via non-receptor mediated endocytosis, as increased uptake resulted in
increased transfection efficiency for the targeted polymer, but not for the untargeted
control. This effect could also be due to potential downstream effects of the peptide in
mediating endosomal escape or nuclear translocation. For each of the polymers, even
though significant uptake is achieved, further evaluation is necessary to understand the
subsequent barriers to transfection that result in relatively low transgene expression in
comparison to viral vectors. A block copolymer with a scrambled peptide may have been
a more ideal targeting control; however the polyplex size, charge and loading are
unchanged by the presence of the peptide, indicating that the PEG control should be a
good control of a non-targeted system. Additionally, our earlier communication [24],
shows that the addition of competing ligand suppresses overall transfection efficiency,
indicating that the uptake of these particles is receptor-mediated.
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Figure 2.2 Uptake of polyplexes formed by targeted and untargeted block
copolymers against PEI.
FITC-labeled polymers were complexed with EGFP plasmids and added to DU145 cells
in 10% serum. Median cell associated fluorescence was measured at 30 min, 1h, and 4h
as indicated in panel A (w/w = 25:1 for block copolymers). Panel B shows the effect of
varying the polymer:DNA ratio of the block copolymers. Fluorescence was measured at 4
h in panel B. PEI was used at an optimized w/w ratio of 2:1. Error bars represent SEM of
5 replicate experiments (*** = p < 0.001, ** = p < 0.01, * = p < 0.05, ns = not
significant).
1.4.4 Endosomal Escape
Endosomal escape is a critical barrier to overcome in the delivery of nucleic acids.
Measurement of endosomal escape is done frequently using fluorescence microscopy
[33]. Commonly, a fluorescent marker for the endosomes (transferrin, fluorophore-
modified dextrans, endosome/lysosome tracking dye) is employed, and escape is
considered achieved if there is no co-localization between the polyplex and the
endosomal marker [34]. However, this is difficult to measure and quantify in high
throughput, thus screening a large library of materials or formulations for differences in
endosomal escape performance is complex. Akinc et al. [35] describe a novel method for
measuring the pH of the polyplex environment via high-throughput flow cytometry, but
here we describe a direct method for quantifying the disruption of the endosome using an
image-based high-throughput screening approach.
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Figure 2.3 High Throughput Endosomal Escape.
Panel A is a schematic of the high-throughput calcein assay used to quantify endosomal
escape. When calcein alone is taken up by cells, it remains in the endosomal
compartments and thus a punctuate pattern of fluorescence in the cytoplasm is visible.
With the addition of an endosomal escape agent, e.g. a polymer or polyplex, the calcein is
released into the cytosol yielding a uniform pattern of fluorescence. The images in panel
A are representative of these morphologies and taken at 20x. The images have been
intensity normalized for this figure in order to more easily visualize the punctuate vs
diffuse pattern of fluorescence. Nuclei are shown in blue, calcein as green. Panel B is a
grayscale image of the calcein channel of DU145 cells treated with G5-PEG-WIFP
polyplexes. The Cellomics algorithm has differentiated cells with endosomal escape (blue
circle overlay) vs. those without (orange circle overlay). In panel C, the concentration of
PEI is increased as is the time in which the cells were exposed to the calcein/escape
agent. Panel D shows the percentage of escaped cells from treatments with various
polyplex formulations in OPTI-MEM with 10% serum. PAMAM based polyplexes were
used at a 25:1 w/w ratio. PEI was used at 2:1 w/w ratio. Error bars are SEM of 3
replicates (*** = p < 0.001, ** = p < 0.01, * = p < 0.05, ns = not significant).
The high-throughput approach uses the fact that calcein is a membrane-
impermeable fluorophore that can be taken up by cells and trafficked through endosomes
to lysosomes, but cannot achieve endosomal/lysosomal escape [36, 37]. In the presence
of an escape agent, calcein will be released and is seen throughout the cell. (Fig. 2.3A).
Using an automated fluorescent microscope, the two phenotypes can be differentiated in
real-time by algorithms using spatial fluorescence information. Figure 2.3B shows a
representative image (20x magnification) in which the algorithm has identified cells
which have undergone endosomal escape vs. those that have not. Figure 2.3C is an
example of an assay validation experiment in which increasing amounts of PEI were
added and the escape measured at different time points. As expected, escape percentage
increased with increasing concentrations of PEI and increasing incubation time. When
applied to the block copolymer systems studied, a similar pattern to that of the uptake and
overall transfection efficiency was observed. The observed escape percentage
relationship between targeted and untargeted PAMAM block copolymers was similar to
that of the uptake, suggesting the endosomal escape properties were relatively unchanged
between the two polymers. This is consistent with the fact that these two polymer differ
only in the presence of a targeting ligand, and thus the pH-responsive PAMAM structure
remains the same. The low escape percentage of the PEI is likely due to its poorer uptake
relative to the block copolymers as its escape percentage is greatly enhanced in the
absence of serum (data not shown).
1.4.5 Nuclear Uptake and DNA Unpackaging
While endosomal escape could be visualized and quantitated using a high-
throughput approach, dissociation of the polyplex and nuclear uptake were followed
using traditional confocal microscopy techniques. In this case, both the plasmid DNA and
polymers were labeled in order to track polyplex dissociation. Figure 2.4 shows
representative images of a 24-hour incubation of dual-labeled polyplexes. There is
substantially more plasmid DNA delivered by the targeted block copolymer in
comparison with the untargeted polymer or PEI. Again, this is due primarily to the
differential uptake between the three systems. Additionally, it is apparent that the
PAMAM-PEG micelles are not completely dissociated, as there is significant co-
localization between the polymer and DNA channels. In the case of the targeted
PAMAM-PEG, it is possible to visualize a yellow core at the center of areas of red
fluorescence, indicating that there is still polymer associated with most polyplexes.
Finally, it is evident that the polyplexes are localized to an area near the nucleus, but not
inside, such as a microtubule organization center (MTOC) [38]. Uptake into the nucleus
should be readily seen 24 hours after initial application, but the fact that it is not observed
with these materials indicates nuclear localization to be a significant barrier to delivery.
The observed gene expression can likely be attributed to either the small percentage of
decomplexed DNA that is non-specifically chaperoned into the nucleus or to cells in
which the nuclear membrane was not intact (e.g. in the process of dividing) [39]. In this
case, some polyplexes accessing the nucleus may still be fully or partially condensed, but
even partially complexed polyplexes could participate in gene transcription [40]. The lack
of efficient nuclear uptake and polyplex decondensation represents a significant barrier to
further transfection efficiency and represents an area in which these polymers can be
improved, possibly by the incorporation of a nuclear localization sequence.
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Figure 2.4 Confocal fluorescence micrographs of cells transfected with
targeted/untargeted block copolymers as well as PEI.
Transfection took place in 10% serum and micrographs were taken on fixed cells 24h
after polyplexes were added. Scale bars are 5 microns. In the merged channel, yellow
indicates colocalization of polymer (green) and DNA (red).
For the targeted block copolymers, nearly 100% of cells took up complexes (see
Supporting Information) , 36% achieved endosomal escape, but only 2% were ultimately
transfected. Less than 6% of cells which experienced escape were transfected by either
targeted or untargeted block copolymer, while over 15% of escaped cells were
transfected by PEI. This underscores that while the escape of these block copolymers
polymers is efficient, downstream events after endosomal escape represent the most
important challenges going forward. Addressing these challenges will be important
because even as currently designed, these promising targeted block copolymers are
capable of superior transfection relative to PEI in the presence of serum.
1.5 Summary
PAMAM-PEG block copolymers have shown promise as gene delivery agents.
Here we have shown this system to be nearly an order of magnitude more potent than PEI
in vitro and have examined the bottlenecks the system faces. While targeted uptake
remains efficient, even in the presence of serum, endosomal escape and unpackaging of
DNA polyplexes afterward could be further improved. To that end, we have
demonstrated a tool to screen libraries of compounds to rapidly determine the best
structures and formulations for endosomal escape. Finally, we have shown that nuclear
translocation appears to be the primary obstacle to more efficient transfection in this
system - further engineering of the system to promote active delivery of polyplexes into
the nucleus could greatly enhance transfection.
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Chapter 3. Crosslinked Linear Polyethyleneimine
Enhances Delivery of DNA to the Cytoplasm
3.1 Abstract
Crosslinked polyethylenimines (PEIs) have been frequently examined over the past
decade since they can maintain the transfection efficiency of commercially available, 25k
branched PEI, but exhibit less cytotoxicity. The argument is often made that the of such
polymers, generally synthesized with either disulfide or hydrolytically degradable
crosslinkers, is critical to the high efficiency and low toxicity of the system. In this work,
we present a crosslinked linear PEI (xLPEI) system in which either disulfide-responsive
or non-degradable linkages are incorporated. As with previous systems, strong
transfection efficiency in comparison with commercial standards was achieved with low
cytotoxicity. However, these properties were shown to be present whether the degradable
or non-degradable crosslinker was used. Free polymer was demonstrated to be the critical
factor determining transfection efficiency for these polymers, mediating efficient
endosomal escape without signs of cell membrane damage. While several crosslinked
PEI systems in the literature have demonstrated the effect of the disulfide moiety, this
work demonstrates that disulfide-mediated unpackaging may not be as important as
conventionally thought for some PEI systems.
3.2 Introduction
Clinical translation of gene therapy requires safe, efficient vectors. While viral
vectors are efficient, remaining concerns regarding safety and immunogenicity have
created a need for efficient synthetic vectors. One of the most studied polymers for DNA
delivery is polyethylenimine (PEI), a polycation with high charge density capable of pH
buffering in physiologically beneficial ranges [1]. PEI, available in either linear or
branched forms, is among the most efficient commercially available polymers, but also
one of the most toxic [2]. It causes an acute cytotoxicity due to cell membrane disruption
followed by induction of apoptosis by destabilization of mitochondrial membranes [3, 4].
Though PEI has frequently been used in both animals and humans for gene delivery, it
has also been shown to aggregate red blood cells, bind complement, and cannot easily be
broken down and excreted [5, 6].
Crosslinked low molecular weight PEIs have emerged as a strategy for
overcoming cytotoxicity while maintaining relatively high transfection efficiency [7, 8].
Of particular interest are crosslinkers that are bioresponsive and can specifically degrade
within the cytoplasm of the target cell [9-12]. Disulfide reduction and hydrolytic
degradation are the strategies primarily employed to trigger intracellular release of DNA
from crosslinked PEIs. PEI crosslinked with hydrolytically degradable crosslinkers has
been shown to have efficiency equal or greater to bPEI 25k, as well as reduced toxicity
[13-17]. Disulfide crosslinked polymers have been designed to take advantage of the
intracellular reducing environment to effect release of the DNA in the cytoplasm [10].
Breunig et. al have shown transfection efficiencies of over 60% with over 90% cell
viability in several cell lines transfected with disulfide crosslinked LPEI [18, 19].
Several other disulfide crosslinked PEI studies have reported efficiencies near or
exceeding that of commercial standards with reduced cytotoxicity [20-22]. While
intracellular disulfide reduction is frequently cited as being an important feature for
excellent transfection and low toxicity, very few studies directly compare disulfide-linked
PEIs with PEIs crosslinked with a non-degradable crosslinker [23]. Some studies have
modulated the intracellular reducing potential with either buthionine sulfoximine (BSO)
or glutathione monomethyl ester (GSHMEE) [24-26], however these methods perturb
normal cell physiology. In this work, we synthesize a series of crosslinked LPEIs
containing either disulfide or non-degradable crosslinkers and evaluate the mechanism of
high transfection efficiency and low cytotoxicity.
3.3 Materials and Methods
3.3.1 Materials
Linear Polyethylenimine (M, of 2500 g/mol and 25000 g/mol) was purchased
from Polysciences (Warrington, PA). Branched 25,000 g/mol (Mw) polyethylenimine
(PEI) and other chemical reagents were purchased from Sigma Aldrich (St. Louis, MO).
KB cells were obtained from ATCC (Manassas, VA). pCMV-EGFP-Nl plasmid DNA
was obtained from Aldevron Inc.(Fargo, ND). All other cell culture reagents were
obtained from Invitrogen (Carlsbad, CA).
3.3.2 Polymer Synthesis
One hundred (100) mg of linear polyethylenimine (LPEI, M, = 2500 g/mol) was
dissolved in a 2:1 mixture of methanol:dimethylsulfoxide (MeOH:DMSO) at a
concentration of 0.33 g/mL. Succinic acid (SA) or dithiodipropionic acid (DTDP) was
dissolved in 2:1 MeOH:DMSO at 0.3 g/mL and added to achieve crosslinker ratios of
0.02 - 0.1 mol crosslinker/mol lPEI monomer (M, = 43 g/mol). N-hydroxysuccinimide
(NHS) was dissolved in 2:1 MeOH:DMSO at 0.4 g/mL and 1.4 equivalents per
carboxylic acid added. After all components were well mixed, 1.4 equivalents of 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide (EDC) dissolved in 2:1 MeOH:DMSO was
added while the mixture was stirred vigorously. This reaction proceeded overnight and
was then dialyzed against Milli-Q water for 2 days using a 12000-14000 MWCO
SpectraPOR membrane. Nondegradable, SA crosslinked xLPEIs are labeled xL-Y, where
Y is the mol % crosslinker (relative to LPEI monomer). Degradable, DTDP crosslinked
polymers are labeled xL-SS-Y. xL-Y 1H-NMR (400MHz, D2 0) 6=2.6 (t, -NCO-CH 2-
CH 2-CON-), 3.0 (m, -CH 2-NH-CH 2 -), 3.45 (t, -CH 2-NCO-CH 2-). xLSS-Y 'H-NMR
(400MHz, H2 0) 6=2.6 (t, -NCO-CH 2- CH 2-S-S-), 6=2.95 (t, -NCO-CH 2- CH 2-S-S-), 3.0
(m, -CH 2-NH-CH 2 -), 3.45 (t, -CH 2-NCO-CH 2-).
3.3.3 Cell Culture
KB cells were cultured in folate-free RPMI 1640 basal media supplemented with
10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin in a
humidified 37*C atmosphere at 5% CO2.
3.3.4 Polyplex Formation
Fifty (50) p.L xLPEI was aliquoted into wells of 96-well plate at concentrations
ranging from 0.333 mg/mL to 0.0033 mg/mL. Twenty-five (25) pL of plasmid DNA at
0.05 mg/mL in PBS was added to each well and mixed well via pipette. Complexes were
allowed to stand for 10 minutes. One hundred (100) pL of a 1:200 (v/v) solution of
Quant-It Picogreen reagent in PBS was added to the wells of an opaque 96-well plate.
Twenty (20) ptL of polyplexes were added to the Picogreen plate and mixed well. After 5
minutes, fluorescence measurements were made (ex. 490/em. 525) on a Tecan Infinite
200 Pro. Measurements were normalized to that of free DNA (100% uncomplexed DNA)
and background Picogreen (0% uncomplexed DNA).
3.3.5 Transfection
Cells were trypsinized prior to transfection and seeded in 96-well plates at 4,000
cells/well overnight in a humidified 37*C atmosphere at 5% CO 2 to be 60% confluent at
the time of treatment. xLPEIs were diluted in PBS at 0.1 mg/mL initially and then further
diluted into 25 ptL of the same buffer in a separate 96-well plate at varying
concentrations. Twenty-five (25) piL of pDNA at 0.05 mg/mL in PBS was then added to
each well and mixed by gentle pipetting. After 10 min for complex formation, 30 pL of
the complexes were added to 200 pL of Opti-MEM. After further mixing, 150 pL of the
complexes in Opti-MEM were added to the cells (after growth media had been removed).
Additional polymer was added either immediately or after 4 hours. After 8 hours, the
complexes in Opti-MEM were removed and growth media was added. Cells were
assayed at 48 hr for GFP production using flow cytometry. 4000 - 10000 live cells per
sample were analyzed.
3.3.6 Flow Cytometry
Flow cytometry was performed in U-bottom 96-well plates using an LSR II HTS
Flow cytometer (Becton-Dickinson, Mountain View, CA). To prepare samples, media
was removed from cells and replaced with 25 tL trypsin for 5 minutes. One hundred
(100) gL of PBS supplemented with 2% FBS and 0.005 mg/mL propidium iodide was
then added to each well, mixed, and the entire 125 pL cell suspension transferred into a
U-bottom 96-well plate.
3.3.7 Polyplex Uptake
Cells were trypsinized prior to transfection and seeded in 96-well plates at 8,000
cells/well overnight in a humidified 37*C atmosphere at 5% CO 2 to be 80% confluent at
the time of treatment. Plasmid DNA was labeled with Rhodamine-CX using a Label-IT
kit from Promega (Madison, WI). Polyplexes were formed and cells treated as described
in the Transfection section, with labeled DNA mixed 1:1 with unlabeled DNA. At the
time indicated, cells were washed twice with PBS and analyzed using flow cytometry. No
propidium iodide was used due to spectral overlap with Rhodamine-CX.
3.3.8 Endosomal Escape
Cells were trypsinized prior to treatment and seeded in black-sided, clear-bottom
96-well plates at 8,000 cells/well overnight in a humidified 37'C atmosphere at 5% CO2
to be 80% confluent at the time of treatment. Cells were treated with 100 piL of Opti-
MEM containing 0.15 mg/mL calcein and varying concentrations of polymer. After 2
hours, the Opti-MEM was removed and cells were washed once with Opti-MEM and
then incubated in Opti-MEM containing 0.1% (v/v) Hoechst 33342 for 20 minutes. After
the cells were washed twice, 150 tL of phenol-free Opti-MEM was added to each well
before the plate was covered with an opaque sticker, foiled, and analyzed. Imaging was
done using a Cellomics ArrayScan VTI HCS Reader (Thermo Fisher, Waltham, MA) and
analysis was done using the included software[27]. 300 - 3000 live cells per sample were
analyzed.
3.3.9 LDH Release
The protocol used was adapted from the manufacturer's instructions of the Cyto-
Tox ONE Assay kit. Cells were trypsinized prior to transfection and seeded in 96-well
plates at 8,000 cells/well overnight in a humidified 370 C atmosphere at 5% CO 2 to be
80% confluent at the time of treatment. Cells were treated with 100 piL of Opti-MEM
containing varying concentrations of polymer. After 2 hours, lysis buffer was added to
untreated cells. After 4 hours, 50 gL of supernatant was removed and added to an opaque
96-well plate.50 tL of Cyto-Tox ONE reagent was added and mixed with gentle
pipetting. After 10 min, 25 tL STOP solution was added and fluorescence was read on a
Tecan Infinite 200 Pro plate reader (ex. 560 nm/ em. 590 nm).
3.3.10 Cell Viability
Cells were trypsinized prior to transfection and seeded in 96-well plates at 4,000
cells/well overnight in a humidified 370 C atmosphere at 5% CO 2 to be 60% confluent at
the time of treatment. Cells were treated with 100 ptL of Opti-MEM containing varying
concentrations of polymer. After 4 hours, polymers were aspirated and wells replenished
with growth media. After 48 hours, 10 piL of a 5 mg/mL solution of MTT reagent (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added. After 4 hours, media
was aspirated and replaced with DMF to dissolve formazan crystals. Absorbance at 570
nm was read on a Tecan Infinite 200 Pro plate reader.
3.4 Results
3.4.1 Synthesis
Low molecular weight LPEIs were crosslinked using EDC and NHS to form higher
molecular weight structures more suitable for gene transfection (Scheme 3.1).
Methanol/DMSO was chosen as the solvent system to enable high concentrations of
reactants that could not be achieved in DMSO or water alone. NMR spectra showed that
the incorporation of the crosslinker was nearly quantitative, however GPC analysis did
not reveal a correlation between crosslinker ratio and molecular weight. Molecular
weights (Mw) generally ranged from 30,000 - 50,000 g/mol. The lack of increase in
molecular weight with greater crosslinker feed ratios is likely due to crosslinker reactions
with methanol to form methyl esters on one of the two functional groups of the
crosslinker (these subsequently hydrolyze to form acid groups during dialysis), thus
decreasing the actual crosslinking while still incorporating a large amount of crosslinker.
The presence of carboxylic acid groups in the xLPEIs with high crosslinker ratios was
confirmed by FTIR. The ratio of the peak intensity of the carboxylic acid group to the
tertiary amide group was much smaller for the 4% crosslinked polymers compared to the
8% crosslinked polymers.
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Scheme 3.1 Synthesis of crosslinked linear polyethylenimine.
3.4.2 Polyplex Formation
Complexation of plasmid DNA was measured by exclusion of Picogreen (Figure 3.2).
Polyplexes were completely complexed at an N/P ratio of 5 - 10 for xLPEI , commercial
IPEIs, and bPEI 1.8k. bPEI 25k completely complexed DNA at an N/P ratio of 3,
consistent with reports from Wu et. al. [28]. The total amount of protection of DNA
decreased with increasing crosslinker ratio. This is likely due to the introduction of
carboxylic acids at high crosslink ratio that neutralize the charge of the amines as
mentioned above. When completely complexed, DNA is still more available to Picogreen
in the xLPEI polyplexes (33%) versus lPEI polyplexes (10%) and bPEI 25k polyplexes
(<5 %). Polyplexes formed by xLPEIs in PBS had zeta potentials that were on average
between 20 and 40 mV, with averaged diameters of approximately 350 - 500 nm.
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Figure 3.2 Complexation of plasmid DNA by crosslinked IPEI as a function of the
percentage of crosslinker incorporated.
3.4.3 Transfection
Transfection of KB cells demonstrated that efficiency was optimal at a crosslinker
ratio of 4% (Figure 3.3). At an N/P ratio of 40:1, 40% efficiency was achieved with over
90% viability, results consistent with those reported for similar materials [18]. This
efficiency was slightly higher than that of bPEI 25k, iPEI 25k, and nearly as strong as
Lipofectamine 2000. As expected, cell viability was much higher with xLPEI, though not
for the xL-2, which contained the lowest feed ratio of crosslinker. Viability increased
monotonically with crosslinking percentage rather than achieving a maximum, as seen
with transfection efficiency. xLPEIs require relatively high N/P ratios in comparison to
bPEI 25k and lPEI, though xL-2 does show some transfection at N/P 10. Figure 3.4
demonstrates that the transfection efficiency of xLPEIs is independent of the
degradability of the crosslinker. Both transfection efficiency and cell viability are
unchanged by the degradation of the crosslinker, suggesting that disulfide degradation
may not be the primary means of DNA release for efficient transfection by these xLPEIs.
Given the relatively weak binding of the xLPEIs, release could be mediated
electrostatically by exposure of the polyplex to the high concentrations of polyionic
species in the intracellular environment. The xLPEIs are readily degraded by DTT as is
consistent with similar systems, thus the similarity in release characteristics is not due to
lack of disulfide degradation as a result of our particular synthetic scheme.
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Figure 3.3 (A) Transfection efficiency of cells transfected with crosslinked IPEI as a
function of crosslinking percentage and N/P ratio. (B) Relative viability of KB cells
transfected in (A).
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Figure 3.4 (A) Transfection efficiency of cells transfected with crosslinked IPEI as a
function of cross-linker degradability. Polyplexes were formed at an N/P ratio of
40:1. (B) Relative viability of KB cells transfected in (A).
3.4.4 Free Polymer Effects
The relatively high N/P ratios at which maximal transfection efficiency was
observed (Figure 3.3A) suggest that a relatively large amount of free polymer is present
in solution during transfection, which has been previously shown to increase transfection
efficiency [28, 29]. To further determine whether disulfide degradation or free xLPEI
polymer was contributing to the higher transfection efficiency of the xLPEIs, the relative
contributions of free polymer versus polyplex-bound polymer were investigated.
Previously, Wu et al. examined the effect of free versus bound polymer by forming
polyplexes at N:P ratios that were below that necessary for optimal transfection but still
able to efficiently condense DNA [28, 30, 31]. Here, uptake, transfection, and
cytotoxicity were measured in two sets of experiments. First, the condensing, or
polyplex-bound, polymer was kept constant as the nondegradable bPEI and the free
polymer was varied (Figure 3.5). Subsequently, the free polymer was held constant (xL-4
used in all cases) while the condensing polymer was varied (Figure 3.6). In both cases,
polyplexes were formed at N/P 10 (for xLPEI) or N/P 5 (for bPEI). These N/P ratios
represent the lowest N/P ratio at which the final, maximum degree of complexation was
reached for each system based on Figure 3.2. No method of separation was used to
remove free polymer as that would result in complexes that were thermodynamically
unstable in media with physiological salt concentrations [29]. The remaining fraction of
free polymer was added either immediately following transfection or 4 hours afterward,
after which the majority of the uptake is expected to have taken place.
Interestingly, it was seen that when bPEI was used as the condensing polymer, the
addition of free xLPEI polymer led to similar -30% transfection efficiency for both
degradable and nondegradable xLPEI (Figure 3.5C). In either case, the polyplexes
formed using bPEI as the condensing polymer would need to undergo unpackaging
without the assistance of degradable linkers, indicating that disulfide degradation is not
responsible for an efficiency boost in this particular system. In fact, under the majority of
conditions studied, there was no significant difference between degradable and non-
degradable xLPEIs. Figure 3.5B shows that cell uptake is high for bPEI 25k, with or
without added polymer; in fact the immediate addition of free polymer, regardless of
composition, had a negative effect on bPEI 25k uptake, agreeing with data from Boeckle,
et. al. [29], who hypothesized that this was a result of competition by free polymer. On
the other hand, when free polymer is added 4 hours later, the original high cell uptake is
recovered. Most importantly, there is no difference in uptake of bPEI 25k polyplexes
when the type of free polymer is varied. Therefore uptake effects cannot explain the
superior transfection of free xLPEI/bPEI25k polyplexes over free bPEI25k/bPEI25k
polyplexes, indicating that the efficiency of xLPEI is likely also due to downstream
events such as endosomal escape. Toxicity was actually increased when xLPEIs were
used as free polymer instead of bPEI 25k, opposite of what may be expected based on
standard transfection with homogenous polyplexes (Figure 3.3B). This may be due to
xLPEI-mediated increased cytosolic delivery of bPEI, increasing the opportunity for
bPEI to interact with mitochondria and cause apoptosis.
In Figure 3.6, different condensing polymers were employed while the free
polymer was kept constant. Here, it can be seen that bPEI is more efficient than xLPEI as
a condensing polymer and does not suffer a drop in transfection efficiency when free
polymer is added at 4 hours instead of immediately (Figure 3.6C). There was also a clear
decrease in transfection efficiency from the xLPEI complexed at the full 40:1 N/P ratio
(Figure 3.6C, "high N/P" bars) to the 10:1 N/P ratio xLPEI polyplex to which the
remaining 30 parts free xLPEI was added immediately (Figure 3.6C, "0 hr" bars). As was
seen in earlier transfections, xLPEI was nearly non-toxic, while bPEI 25k showed
significant toxicity when used as the condensing polymer (Figure 3.6D).
The xLPEI samples xL-4 and xL-SS-4 behave similarly despite differences in
degradability, as noted above. For these systems, the addition of free polymer is
necessary to observe any uptake at all by cells (Figure 3.6B). In the presence of
immediately added xLPEI, there is a significant boost in cell uptake (60%); when free
polymer is added after 4 hours; however, the delay leads to a decrease in uptake by cells
to 30 - 35% (Figure 3.6B). This fact, combined with the fact that uptake not seen at all
when no additional polymer is added, suggests that uptake is decreased when the DNA
polyplexes are incubated in the cell culture media for extended periods, perhaps due to
gradual aggregation or the destabilization of the complexes in culture conditions over
time. Cellular uptake for the xLPEI complexes thus appears to be dependent on the
presence of additional polymer; this additional polymer may interact with the cell
membrane or further condense particles to facilitate entry of the polyplexes to the cell.
However, the size of polyplexes formed in Opti-MEM is not significantly reduced when
free polymer is added. While further complexation by free polymer may play some role
in increasing uptake for the loosely binding xLPEI as Fig 3.6B suggests, Figures 3.5B
and 3.5C show that it is clearly impacting the transfection process downstream of uptake
as well, likely by enhancing endosomal escape.
Mdition of *ee
polymer at 0 or 4 hrs
x,- N"
xt-SS-4
bPEI
Uptake
-- + Transfection
EMesencyCciyJ
m+free poiyrflef at 0 hr
+free polymer at 4 hr
- -free polymner
C
C 40
* 30
~20
0 L10
U.
00
* 100
~40
9
~20,
S 0
100
C
! 6
140
S20
Figure 3.5 xLPEI Function as Free Polymer
(A) Experimental schematic. KB cells were treated with bPEI polyplexes formed at an
N/P ratio of 5 and supplemented with free polymer at either 0 or 4 hours. Cells treated
with polyplexes formed at N/P 10 or N/P 5 and unsupplemented with free polymer were
present as controls. Free xLPEI (xL-4 - succinic acid crosslinked, non-degradable, xL-
SS-4 - disulfide linked, degradable) was added to form a total N/P ratio of 40. Free bPEI
was added to form a total N/P ratio of 10. (B) Percentage of cells taking up Rhodamine-
CX labeled DNA polyplexes as measured by flow cytometry 6 hours after initial
treatment. (C) Percentage of GFP positive cells 48 hours after initial treatment. (D)
Percentage of live cells 48 hours after live treatment as measured by propidium iodide
staining.
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Figure 3.6 xLPEI Function as Condensing Polymer
(A) Experimental schematic. KB cells were treated with polyplexes formed at an N/P
ratio of 5 (bPEI) or 10 (xLPEI) and either supplemented with free xL-4 polymer at 0 or 4
hours, or not supplemented at all. Cells treated with polyplexes formed at optimal high
N/P ratios (xLPEI - N/P = 40, bPEI - N/P = 10) and unsupplemented with free polymer
were also present as controls. Free xL-4 was added to form a total N/P ratio of 40. (B)
Percentage of cells taking up Rhodamine-CX labeled DNA polyplexes as measured by
flow cytometry 6 hours after initial treatment. (C) Percentage of GFP positive cells 48
hours after initial treatment. (D) Percentage of live cells 48 hours after live treatment as
measured by propidium iodide staining.
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3.4.5 Endosomal Escape
To determine the efficiency of free polymer in facilitating endosomal escape, a
high-throughput calcein assay was used as previously described [27]; results of the assay
are shown in Figure 3.7A for each of several PEI polymer systems. xLPEIs proved to be
able to cause significant endosomal escape at concentrations between 3 and 10 pg/mL,
with a steep increase in efficiency above a critical concentration, up to over 80%. In
contrast, commercial LPEI's showed a more gradual increase in escape, facilitating
calcein escape in over 50% of cells at 10 pg/mL. bPEI 25k was also able to cause calcein
release at 10 pg/mL, while bPEI 1.8k was not able to effect any release up to 30 ptg/mL.
Interestingly, the commercial PEIs showed a decrease in escape with concentrations
above 10 pg/mL, possibly due to calcein leaking out of the cells entirely as a result of
membrane damage. In order to determine the extent of membrane destabilization by the
xLPEIs, LDH leakage was measured as a function of free polymer concentration (Figure
3.7B). 25k bPEI and lPEI showed significant membrane damage above 3 pg/mL, as did
lPEI 2.5k. Both xLPEI species did not show any membrane damage at concentrations up
to 30 pg/mL, despite facilitating escape in over 75% of cells at this concentration.
xLPEIs also demonstrate a - 1.5 log increase in LD50, with no toxicity effects at 10
ig/mL, the concentration at which escape becomes highly efficient (Figure 3.7C).
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Figure 3.7 Toxicity and Endosomal Escape of free PEI
(A) Activity of lactate dehydrogenase (LDH) in the supernatant of cells treated with
crosslinked and commercial PEIs. (B) Percentage of cells exhibiting endosomal escape in
high-throughput calcein assay (see methods) when treated with crosslinked and
commercial PEIs. (C) Relatively viability of cells as measured by an MTT assay
3.5 Discussion
As mentioned in the introduction, different PEI crosslinking techniques have been
reported, generally utilizing either a bifunctional crosslinker or derivitizing primary
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amines into thiols for subsequent disulfide formation. We opted to use EDC coupling, as
it requires only dicarboxylic acid functionality from the crosslinker, which can be
designed to be responsive to various stimuli; furthermore, the crosslinking can be
achieved in a one-pot approach in various solvents depending on the solubility of the
crosslinker. The choice of polycation may also be varied, as only primary or secondary
amines are required for crosslinking - here lPEI was chosen due to favorable efficiency
and toxicity reports from previous work [18]. This synthetic approach is potentially
amenable to a combinatorial development with a library of polycations and linkers
responsive to different stimuli. For this study, a reducible and non-reducible crosslinker
were chosen for incorporation. While crosslinker functionality was the critical feature for
this design, the lengths were slightly different and thus a future study on the impact of
crosslinker length could be of interest. The approach taken here resulted in crosslinked
polymers with nearly quantitative integration of crosslinker. However, as noted in the
results section, the presence of methanol in the solvent system resulted in free carboxylic
acid formation at higher crosslinker ratios, decreasing the positive charge and limiting the
molecular weight. Wu et al demonstrates the effect of controlled addition and an oxygen-
free environment on the crosslinking of bPEI [32], however we wanted to keep the
synthesis simple and scalable for future combinatorial implementation.
xLPEI was able to form polyplexes, though xLPEI polyplexes were looser than
those formed with commercial bPEI 25k. DNA was more accessible, even at very high
N/P ratios, than the 25k standards, likely a result of reduced net charge and thus efficacy
of DNA condensation. Gosselin et. al demonstrated how different crosslinker chemistry
could be used to avoid this charge neutralization [7]. Transfection efficiencies achieved
by xLPEIs agree well with those previously reported for KB cells [18]. The decrease in
efficiency at higher crosslinking ratios is likely explained by the high amount of charge
neutralization and poor complexation efficiency. Cell viability increases monotonically
with crosslinker ratio, and hence charge neutralization, which may be the primary
mechanism for decreased toxicity at the higher crosslink densities. At high N/P ratios,
toxicity is likely dominated by free polymer effects, thus changes in polyplex size or
charge should not have an impact on toxicity. Of great interest was the fact that both
transfection efficiency and cell viability varied independently of crosslinker choice. This
indicates that disulfide degradation may not be critical for either transfection or reduced
toxicity in this xLPEI system.
The high transfection efficiencies shown in Figure 3.3 were achieved at high N/P
ratios, indicating that free polymer likely plays an important role in transfection. Wu, et.
al found that in a typical N/P 10 formulation of bPEI 25k, approximately 70% of the
bPEI is free in solution. This agreed well with results from Wagner in which size
exclusion chromatography was used to separate free polymer from polyplexes [29]. In
both studies, it was found that transfection efficiency in the absence of free polymer was
two orders of magnitude less efficient, but could be restored by the addition of free
polymer, either immediately or several hours after initial polyplex addition. To
investigate whether the high transfection efficiency was due to superior properties of
xLPEI as free polymer, as a DNA condensation agent, or some combination of the two, a
series of experiments was carried out in which bPEI 25k was substituted for xLPEI for
the above functions. The increase in transfection efficiency when xLPEI is used as free
polymer along with bPEI 25k polyplexes indicates free xLPEI plays an important role in
the increased transfection efficiency. To determine if the free polymer was functioning
primarily to stimulate uptake of polyplexes, polyplex uptake was measured using labeled
DNA. When bEI 25k was used to form polyplexes, uptake was relatively independent of
free polymer addition, indicating the primary role of free xLPEI was downstream of
uptake. Cell viability was dependent on both the choice of condensation polymer and free
polymer, as systems with bPEI 25k included in either capacity experienced significant
cytotoxicity. Differences in either efficiency or viability between degradable and non-
degradable xLPEI were absent in most cases. This is consistent with xLPEI free polymer
being the dominant factor in generating high transfection levels, as cytosolic polyplex
unpackaging, a property improved by disulfide degradation, would not depend on free
polymer.
In experiments in which xLPEI was kept constant as the free polymer, uptake was
greater when bPEI 25k was used as the condensing polymer versus xLPEI. xLPEI was
shown to be inefficient at both uptake and transfection in the absence of free polymer,
suggesting that free polymer may be necessary for additional complexation prior to
uptake. Additional polyplex condensation by free polymer was not seen in sizing
experiments, but Figure 3.6 still suggests some role for this process. The role of free
xLPEI in this system thus depends on the identity of the polyplex used; for loose
polyplexes it serves to additionally complex polyplexes after addition and for all
polyplexes it enhances transfection processes downstream of uptake, such as endosomal
escape.
Endosomal escape was probed rapidly using a high-throughput implementation of
a calcein release assay reported previously by our group [27, 33]. xLPEIs were able to
mediate escape in over 60% of cells at 10 D g/mL, the approximate concentration of free
polymer in a 40:1 N/P formulation. In comparison, bPEI 25k caused escape in less than
10% of cells at 3 E0 g/mL, approximately the concentration at which free polymer exists at
the optimized bPEI 25k formulation of N/P 10:1 [28]. bPEI 25k was effective in causing
escape at 10 E g/mL, but at slightly lower efficiencies than xLPEI, and causing
significant membrane damage. This membrane damage also manifested itself as a loss of
calcein at 30 Eg/mL. However, xLPEI showed no evidence of membrane damage at 30
OZg/mL, a concentration at which escape was seen in over 75% of cells. Overall cell
viability was also shown to be substantially better for xLPEI and no loss of viability was
seen at 10 Dg/mL, the concentration which achieved escape in over 60% of cells. Taken
together, this shows that free xLPEI is able to effectively mediate endosomal escape
without the membrane toxicity observed in commercially available PEIs.
In summary, we have shown that polycations crosslinked with a disulfide linkage
are not necessarily highly efficient and less toxic as a result of the disulfide linkage itself.
In the case of the xLPEIs synthesized in this work, free polymer was shown to be
primarily responsible for the high efficiency and decreased toxicity of this system. Free
xLPEI was shown to be effective in mediating endosomal escape with no observed
membrane toxicity. More investigation into the role of free polymer in delivery of DNA
will increase the understanding of how polymer structure and delivery function are
related.
3.6 Summary
In summary, we have shown that polycations crosslinked with a disulfide linkage
are not necessarily highly efficient and less toxic as a result of the disulfide linkage itself.
In the case of the xLPEIs synthesized in this work, free polymer was shown to be
primarily responsible for the high efficiency and decreased toxicity of this system. Free
xLPEI was shown to be effective in mediating endosomal escape with no observed
membrane toxicity.
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Chapter 4. Evaluation of siRNA Delivery with Clickable
pH Responsive Cationic Polypeptides and Block
Copolymers
4.1 Abstract
A series of pH responsive synthetic polypeptides has been developed based on an N-
carboxyanhydride ring opening polymerization combined with a facile and versatile click
chemistry. Poly(y-propargyl L-glutamate) (PPLG) homopolymers and poly(ethylene
glycol-b-y-propargyl L-glutamate) (PEG-b-PPLG) block copolymers were functionalized
with various amine moieties that range in pKa and hydrophobicity, providing the basis
for a library of new synthetic structures that can be tuned for specific interactions and
responsive behaviors. Here we evaluate the pH responsive behavior of the new
polypeptides and the hydrolysis of the ester containing amine side chains. We examine
the reversible micellization with block copolymers of the polypeptides and evaluate the
siRNA delivery potential of this library. While this PPLG library was able to efficiently
complex siRNA, gene-specific knockdown could not be achieved. Analysis of barriers to
transfection demonstrated that adequate uptake was followed by an inability to escape the
endosome, most likely due to low charge density.
4.2 Introduction
Synthetic polypeptides have received attention because of their unique structural
properties and biocompatibility [1-4]. Like their naturally occurring analogs, these
molecules have a poly(amino acid) backbone and possess the ability to fold into stable
secondary structures. Helical structures, in particular, allow for proteins to optimally
display surface moieties that dictate cell signaling and molecular docking [5]. This
property gives synthetic polypeptides an advantage over most traditional polymers that
can only adopt a random coil structure. A considerable amount of research has been
performed on synthetic polypeptides to better understand the complex features of proteins
and to gain insight into their secondary structures [6-10]. Synthetic polypeptides can be
synthesized on a large scale by the ring opening polymerization (ROP) of N-
carboxyanhydrides (NCA) formed from naturally occurring amino acids. These simple
homopolypeptides are able to arrange into or change their secondary structure based on
solution conditions [7-10]. Although these macromolecules' secondary structure can be
controlled to some extent, we are limited by the given side chain, which dictates polymer
function, structure, and responsive behavior to temperature or pH among many other
properties.
Recently, we reported a new approach to the manipulation of synthetic
polypeptide composition and function through the introduction of a new NCA polymer,
poly(y-propargyl L-glutamate) (PPLG) [11], which contains a pendant alkyne group that
can be reacted with an azide by the alkyne-azide cycloaddition click reaction [11, 12].
This synthetic strategy allows for the convenient and efficient functionalization of a
polypeptide without the need for protection and deprotection steps. To demonstrate the
efficiency of polymer modification, we used a model PPLG-g-PEG system, for which we
were able to attain a "grafting onto" efficiency of over 96% [11]. Since our initial report,
other research groups have extended this platform methodology of combining NCA
polymerization and click chemistry side chain modification. Chen et al. used PPLG to
click on several different azide functionalized monosaccharides to form
glycopolypeptides [13]. Tang and Zhang reported the synthesis of poly(y-azidopropyl-L-
glutamate), which was functionalized with alkyne containing mannose moieties via the
alkyne-azide cycloaddition click reaction [14]. Sun and Schlaad developed thiol-ene
clickable polypeptides, where they synthesized poly(D,L-allylglycine) and clicked on
thiol functionalized sugars [15]. Huang et al. synthesized poly(D,L-propargylglycine)
and clicked on azide containing protected galactose, using alkyne-azide cycloaddition
click chemistry [16].
By employing our PPLG platform for the click chemistry of amino-functional
groups, we have developed several new pH responsive macromolecules. A unique aspect
of these new amine-functionalized polypeptides is the ability to buffer and in some cases,
undergo a solubility phase transition with degree of ionization, while adopting an a-
helical structure over biologically relevant pHs. These polymers include both poly(y-
propargyl L-glutamate) (PPLG) based homopolymers and poly(ethylene glycol-b-y-
propargyl L-glutamate) (PEG-b-PPLG) block copolymers substituted with various amine
moieties that range in pKa and hydrophobicity, providing the basis for a library of new
synthetic structures that can be tuned for specific interactions and responsive behaviors.
The new PPLG based cationic polypeptides have the potential to be used for
many different applications. Polypeptides have been investigated as smart molecules in
lipid membranes [17-19], liquid crystals used in optical storage and display devices [4],
vehicles for drug and gene delivery [3, 20-29] , anti-fouling coatings [30], components
for tissue engineering and biosensors, and synthetic mimics of naturally occurring
molecules [1, 3, 31-34]. We have characterized the pH responsive behavior of the new
polypeptides, the pH-dependent hydrolysis rate of the ester containing amine side chains,
and have performed preliminary experiments that demonstrate the potential use of these
new materials for systemic drug and gene delivery. More specifically, for pH responsive
drug delivery, one could design a micellar system that forms stable micelle drug carriers
in the blood stream and normal tissue at extracellular conditions (pH 7.00-7.45) [35] but
destabilizes in the endosome (early endosome pH 5.5-6.3 and late endosome pH < 5.5 )
[36] or in hypoxic regions of tumors (pH approaching 6.0) [35], to release the drug. To
achieve this behavior, a pH responsive polypeptide is needed that is fully soluble at
endosomal or tumor pH and insoluble at extracellular pH. We have determined the
solubility behavior of the amine functionalized PPLG and the self-assembly behavior of
the amine functionalized PEG-b-PPLG as a function of pH. For gene delivery, it is
critical that the polymers complex with siRNA or DNA to form protective polymer-gene
complexes (polyplexes); these polyplexes must escape the endosomal compartments into
which they are initially trafficked upon internalization [37, 38]. One such mode of
endosomal escape is through the so-called "proton sponge effect", in which the basic
polymer buffers the endosome during acidification, leading to osmotic swelling and
rupture [37, 39]. The buffering capacity of the new polypeptides has been explored using
titrations to determine the pH range at which these polymers buffer. In addition, siRNA
delivery studies have been performed to determine if these polymers can efficiently
deliver siRNA and achieve knockdown. We are interested in using the PPLG system for
siRNA delivery because it is particularly amenable to modification with different ratios
of primary, secondary, or tertiary amines. This allows for the precise tuning of the
functions of DNA binding and release (primary and secondary) versus endosomal escape
(secondary and tertiary).
An additional unique aspect of these new polypeptides is that there is an ester
linkage between the amine and the polymer backbone. These ester side chains can be
hydrolyzed, leaving behind a carboxylic acid moiety, thus creating a charge shifting
polymer (shifting with hydrolysis from positive to negative net charge). We have
examined the rate of hydrolysis of the ester side chain at various pH conditions and the
role the shift in overall polymer charge plays on disrupting the secondary structure. This
hydrolysis and overall shift in charge from positive to negative could play a role in
improving the safety and biodegradability of these substituted poly(y-glutamic acid)
based polymers [40-42], and may also aid in the delivery and subsequent unpackaging
and release of nucleic acid based cargos that are delivered using these systems.
4.3 Materials and Methods
4.3.1 Materials
L-(+)-glutamic acid, 99% minimum was purchased from EMD Chemicals. 3-
dimethylaminopropylchloride hydrochloride, 99% was purchased from Arcos Organics.
Sunbright@ amine terminated poly(ethylene glycol) was purchased from NOF
Corporation. siRNA was purchased from Dharmacon RNAi Technologies and QuantiT
Ribogreen RNA Reagent was purchased from Invitrogen. All other chemicals were
purchased from Sigma Aldrich. HeLa cells stabling expressing both firefly and Renilla
luciferease were generously provided by Alnylam (Cambridge, MA) [43]. All materials
were used as received. Dual-Glo Luciferase Assay System was purchased from Promega.
All other cell culture reagents were obtained from Invitrogen (Carlsbad, CA).
4.3.2 General Methods
'H-NMR and "C NMR were recorded on Bruker 400 MHz FT-NMR spectrophotometer.
Gel permeation chromatography measurements were carried out using a Water Breeze
1525 HPLC systems equipped with two Polypore columns operated at 75*C, series 2414
refractive index detector, series 1525 binary HPLC pump, and 717 plus autosampler.
Waters' Breeze Chromatography Software Version 3.30 was used for data collection as
well as data processing. DMF with 0.01M LiBr was the eluent for analysis, and samples
were dissolved at 4-6mg/mL in DMF. The average molecular weight of the sample was
calibrated against narrow molecular weight poly(methyl methacrylate) standards.
Acid-base titrations were performed on all amine functionalized PPLG. 3mL of
10mM amine in 125mM NaCl was adjusted to a pH of 3 using 1 M HCl. The solution
was titrated with 10 p.L aliquots of 0.1 M NaOH, measuring the pH with each addition.
For polymers where precipitation was observed, UV/Vis measurements were obtained at
600nm to monitor the solution turbidity. UV/Visible measurements were carried out on
an Agilent Technologies G3172A spectrometer.
4.3.3 Synthesis of y-propargyl L-glutamate hydrochloride
L-glutamic acid (15g, 102mmol) was suspended in propargyl alcohol (550 mL) under
argon. Chlorotrimethylsilane (28.5mL, 224mmol) was added dropwise to the suspension
over 1 hour. The resulting solution was stirred at room temperature for two days until
there was no undissolved L-glutamic acid. The reaction solution was precipitated into
diethyl ether giving a white solid. The crude product was removed by filtration,
dissolved in boiling isopropanol, and precipitated into diethyl ether. The product was
filtered, washed with diethyl ether, and dried under vacuum to yield 19.13g (84.5%). 'H-
NMR (400MHz, D2 0) 6=2.20 (m, 2H, CH2), 2.63 (dt, 2H, CH-CO), 2.86 (t, 1H, C=CH),
4.05 (t, 1H, CH), 4.69 (d, 2H, CH2 CO).
4.3.4 Synthesis of N-carboxyanhydride of y-propargyl L-glutamate
(PLG-NCA)
y-propargyl L-glutamate hydrochloride (6g, 27mmol) was suspended in dry ethyl
acetate (190mL). The solution was heated to reflux and triphosgene (2.67g, 9mmol) was
added. The reaction solution was refluxed for 6 hours under nitrogen. The reaction
solution was cooled to room temperature and any unreacted y-propargyl L-glutamate
hydrochloride was removed by filtration. The reaction solution was then cooled to 5*C
and washed with 190 mL of water, 190 mL of saturated sodium bicarbonate, and 190 mL
of brine all at 5*C. The solution was then dried with magnesium sulfate, filtered, and
concentrated down to viscous oil (4.53g, 79.2% yield). 'H-NMR (400MHz, CDCl3)
6=2.20 (dm, 2H, CH2 ), 2.49 (t, 1H, C=CH), 2.58 (t, 2H, CH-CO), 4.39 (t, 1H, CH), 4.68
(d, 2H, CH2CO), 6.5 (s, 1H, NH).
4.3.5 Synthesis of Poly(y-propargyl L-glutamate) initiated by
heptylamine
A typical procedure for the polymerization is as follows. To a flame dried Schlenk flask,
heptylamine (14.5pL, 0.0980 mmol) and DMF (8mL) were combined under Ar. In a
separate vial, PLG-NCA (1.552, 7.35 mmol) was dissolved in DMF (8mL) and added to
the reaction flask. The reaction mixture was stirred for three days at room temperature.
The polymer was precipitated into diethyl ether and removed by centrifugation (0.823g,
67.0% recovered, by 'H-NMR n=75, by DMF GPC M,=14,100, PDI=1.09). 'H-NMR
(400MHz, [D6] DMF) 8=2.28 (br m, 2H, CH2 ), 2.55 (br m, 2H, CH-CO), 3.38 (br m, 1H,
C=CH), 4.09 (br m, 1H, CH), 4.76 (br m, 2H, CH2CO), 8.5 (br m, 1H, NH).
4.3.6 Synthesis of Poly(ethylene glycol)-b-Poly(y-propargyl L-
glutamate)
A typical procedure for the polymerization is as follows. A round bottom flask was
rinsed with acetone and oven dried. In a glove box, PEG-NH 2 (0.900g, 0.180mmol) was
dissolved in DMF (9mL) in a round bottom flask. PLG-NCA (0.950g, 4.50mmol) was
dissolved in dry DMF (9mL) added to the reaction flask. The reaction mixture was
stirred for three days at room temperature. The reaction solution was concentrated with a
rotary evaporator and dried under high vacuum to remove the DMF. To remove any
residual PLG-NCA and DMF, the polymer was redissolved in dichloromethane
precipitated into diethyl ether and removed by centrifugation (1.45g, 87.9% recovered, by
H-NMR n=23, by GPC PDI=1.09 ). 'H-NMR (400MHz, [D6] DMF) 6=2.28 (dm, 2H,
CH 2 PPLG), 2.55 (dm, 2H, CH-CO PPLG), 3.38 (m, 1H, C=CH PPLG), 3.59 (s, 4H,
CH 2CH 2 PEG), 4.09 (m, 1H, CH PPLG), 4.76 (m, 2H, CH2 CO PPLG), 8.5 (m, lH, NH
PPLG).
4.3.7 Synthesis of 2-bromo-N-methylethanamine hydrobromide
2-bromo-N-methylethanamine hydrobromide was synthesized following the protocol
presented by Shutte et al [44]. Briefly, in a round bottom flask, 48% w/w HBr (30mL)
was cooled in an ice bath to 4*C and 2-(methylamino)ethanol (10 mL, 125mmol) was
added dropwise. H2 0 and HBr were distilled off and the crude product solution was
cooled to 60'C. The solution was slowly added to a solution of cold acetone, where it
precipitated out to form a white solid. The precipitant was removed, washed with cold
acetone, and dried under high vacuum (16.46g, 60.4% yield). 'H-NMR 6 (400MHz,
D20) 3.69 (t, 2H, BrCH 2), 3.50 (t, 2H, CH 2N), 2.75 (s, 3H, CH 3).
4.3.8 General synthesis of amino azides
Organic azides can be EXPLOSIVE! A guide to safe handling and storage of organic
azides can be found in "Click Chemistry: Diverse chemical function from a few good
reactions" by Kolb et al [12]. The shorthand notation for each side group used in this
article is provided in parentheses after the specific chemical name. Amino azides were
synthesized using the protocol presented by Carboni et al [45]. A representative
example, 3-dimethylamino-l-propylchloride hydrochloride (10g, 63 mmol) and sodium
azide (8.22g, 126 mmol) were dissolved in water (1mL/mmol) and heated at 75*C for 15
h. The reaction mixture was cooled in an ice bath and NaOH (4g) was added. The
solution phase separated and the organic phase was removed. The aqueous phase was
extracted with diethyl ether twice. The organic layers were combined, dried with
MgSO 4 , and concentrated down to an oil (6.60g, 80.8% yield). 3-Azido-N,N-
dimethylpropan-1-amine (dimethylpropanamine) 1H-NMR (400MHz, CDCl3) 6 (ppm) =
3.30 (t, 2H, N 3CH2), 2.30 (t, 2H, CH2N), 2.17 (s, 6H, N(CH 3 )2), 1.71 (m, 2H,
N3CH2CH2). 2-Azidoethanamine (primary amine) 'H-NMR (400MHz, CDCl 3) 6 (ppm)
= 3.32 (t, 2H, N 3CH 2), 2.83 (t, 2H, CH 2NH2 ), 1.45 (s, 2H, NH2). 2-Azido-N-
methylethanamine (Secondary amine) 'H-NMR (400MHz, CDCl3) 6 (ppm) = 3.45 (t, 2H,
N3CH2), 2.72 (t, 2H, CH2NH), 2.39 (s, 3H, CH3 ), 1.28 (s, 1H, NH). 2-Azido-N,N-
dimethylethanamine (Dimethylethanamine) 'H-NMR (400MHz, CDCl 3) 6 (ppm) = 3.32
(t, 2H, N3 CH2 ), 2.47 (t, 2H, CH 2N), 2.24 (s, 6H, N(CH 3)2). 2-Azido-N,N-
diethylethanamine (diethylamine) 1H-NMR (400MHz, CDCl 3) 6 (ppm) = 3.25 (t, 2H,
N3CH2), 2.62 (t, 2H, CH2CH2N), 2.52 (q, 2.54, N(CH 2CH3)2), 1.00 (s, 6H, (CH 2CH 3)2).
N-(2-azidoethyl)-N-isopropylpropan-2-amine (diisopropylamine) 'H-NMR (400MHz,
CDCl3) 8 (ppm) = 3.01 (t, 2H, N3CH 2), 2.98 (m, 2H, N(CH(CH 3) 2)2), 2.62 (t, 2.54,
CH2N), 0.99 (d, 12H, (CH 2(CH 3) 2)2).
4.3.9 General synthesis of substituted PPLG
A typical procedure started with a feed ratio of alkyne/azide/CuBr/PMDETA equal to
1/1.2/0.1/0.1. The PPLG (0.0750g, 0.45mmol alkyne repeat units), amino azide (0.069g,
0.54mmol 3-azido-N,N-dimethylpropan-1-amine), and PMDETA (9.4 iL, 0.045mmol)
were all dissolved in DMF (3mL). The solution was degassed by bubbling argon through
the solution for 20 minutes. CuBr catalyst (0.0064g, 0.045mmol) was added, and the
reaction solution was stirred at room temperature, under argon. Once the reaction was
complete, the reaction solution was purified by dialysis against water acidified by HCl
(pH<4) for 2-3 days, followed by dialysis with Milli-Q water to remove acid before
freeze drying. The final polymer was a white solid.
4.3.10 Circular Dichroism
Circular dichroism (CD) spectroscopy of polymer solutions was carried out using
an Aviv model 202 CD spectrometer. Measurements were performed at 25 ± 0.1*C,
sampling ever nm with a 3-5 s average time over the range of 195-260 nm (bandwidth =
1.0 nm). Measurements were taken using a cell with a 1mm path length. Samples were
prepared at a concentration of 0.5-1 mg/mL in either buffer solutions or Mille-Q water
with pH adjusted using 0. 1M NaOH and 0. 1M HCl solutions.
Critical Micelle Concentration
Critical micelle concentration measurements of the diblock polymers in aqueous
solutions at different pH values were performed by fluorescence spectroscopy using a
pyrene probe. Fluorescence peak intensity emissions ratios (373 nm/ 384 nm) were
plotted against the logarithm of polymer concentrations to determine CMC as the onset of
micellization [46]. Fluorescence spectroscopy was carried out on a Horiba FluoroLog@-
3 spectrofluorometer at 25 *C. A stock solution of pyrene at 5.00 x 10-7 M in water was
prepared. Polymer samples were dissolved in the stock pyrene solution and diluted to
specific concentrations.
Tapping-mode atomic force microscopy (AFM) measurements were conducted in
air with a Dimension 3100 system (Digital Instruments, Santa Barbara, CA) operated
under ambient conditions. The samples were prepared for AFM analysis by spin coating
a silicon wafer with a polymer solution at a concentration of 1 mg/mL in Milli-Q water
with the pH adjusted using 0. 1M NaOH.
4.3.12 Ester Hydrolysis
Ester hydrolysis samples were prepared by dissolving polymer in a stock solution at 10
mg/mL for homopolymer and 20 mg/mL for diblock copolymer. The stock solutions
were then diluted with pH buffer to a concentration of 0.5 mg/mL for homopolymer and
1 mg/mL for diblock copolymer. At various time points, samples were analyzed by CD.
Samples were also freeze dried, reconcentrated in D20 to 2.5 mg/mL for homopolymers
and 3.75 mg/mL for diblock copolymers, acidified with trifluoroacetic acid to stop
hydrolysis, and analyzed by 'H-NMR.
4.3.11
4.3.13 siRNA Complexation and Dissociation
Ribogreen assays (QuantiT Ribogreen RNA Quantification Reagent, Invitrogen)
were performed to determine the complexation efficiency of the polymers with siRNA.
Ribogreen is a cyanine dye that is nearly non-fluorescent when unbound to RNA, but
exhibits a >1000 fold enhancement in fluorescence when bound to RNA. When siRNA is
complexed (e.g. by a polymer), it is unavailable to bind to Ribogreen and thus the
fluorescence signal decreases relative to uncomplexed siRNA. 25 pLL of siRNA at 0.006
pg/mL was aliquoted into wells of a 96 well plate and the appropriate amount of polymer
was added to attain the desired polymer:siRNA ratio (w/w) in a total volume of 50 pL.
After allowing 10 minutes for complexation, 20 p.L of the complex solution was added to
a black, flat-bottomed, polypropylene 96-well plate containing 100 pL of Ribogreen
(diluted 1:200 per manufacturer instructions). The fluorescence of each well was
measured on a Perkin Elmer Plate 1420 Multilabel Counter plate reader and the fraction
of uncomplexed siRNA was determined by comparing the fluorescence of the polymer
complexes with the fluorescence of a free siRNA control. For the heparin destabilization
titrations, heparin (167 IU/mg) was dissolved in a stock solution at 0.5 IU/mL and added
to polyplex/ribogreen solutions.
4.3.14 siRNA Knockdown
Transfection studies were performed in quadruplicate. HeLa cells were grown in
96-well plates at an initial seeding density of 2000 cells/well cell growth media
comprised of Dulbecco's Modified Eagle Media (DMEM) supplemented with 10% fetal
bovine serum (FBS) and 1% Pennicilin-Streptomycin. Cells were allowed to attach and
proliferate for 24 hours in a humidified incubator at 37*C and 5% CO2. 25 pL of siRNA
at 6 pg/mL in 25mM sodium acetate buffer was aliquoted into wells of a 96 well plate
and the appropriate amount of polymer was added to attain the desired polymer:siRNA
ratio (w/w) in a total volume of 50 gL/well. After mixing the polymer/siRNA solutions,
the polyplexes were allowed to sit 10 minutes for complexation. 30 pL aliquots of the
polyplex solution was then added to each well of a 96-well plate containing 200 pL/well
Opti-Mem and the solution was mix. Growth media was removed from the cells and 150
pL/well of complex/Opti-Mem solution was added. Lipofectamine at a 4:1 ratio was
used as a positive control. Naked siRNA was used as a negative control and as an
internal standard. In all cases, the each well contained 50 ng or 150 ng siRNA. The cells
were incubated for 4 hours, the media was removed and replaced with 10% serum-
containing growth medium. A Luciferase assay was performed as using the Dual-Glo
Luciferase Assay System (Promega, Madison, WI).
4.3.15 Cell viability
HeLa cells were seeded in a 96-well clear, flat-bottomed plate and transfected
according to the above protocol. After 24 hrs, cell metabolic activity was assayed using
the MTT cell proliferation assay (ATCC, Manassas, VA).
4.3.16 Polyplex Uptake
Block copolymers and PEI were labeled with fluorescein isothiocyante (FITC) at a molar
ratio of 4:1 (dye:polymer). Using the labeled polymers, polyplexes were formed and
cells treated as described in the above section. At the time indicated, cells were removed
from the incubator and analyzed using flow cytometery. Flow cytometry was performed
in U-bottom 96-well plates using a HTS LSR II Flow cytometer (Becton-Dickinson,
Mountain View, CA). To prepare samples, media was removed from cells and replaced
with 25 gL trypsin for 5 minutes. 50 pL of PBS supplemented with 2% FBS was then
added to each well, mixed, and the entire 75 gL cell suspension transferred into a U-
bottom 96-well plate.
4.3.17 High-Throughput Endosomal Escape
Complexes were assembled and transfection was conducted as described above, except
that 25 pM Calcein was added to the Opti-MEM and cells were seeded in black, clear-
bottom 96-well plates. 4 hours after transfection, 5 pL of a solution of Hoechst 33342
diluted to 1:30 in PBS was added. After 20 min of staining, complexes and free dye were
removed, and the cells were washed 3 times with PBS. 150 pL of phenol-free Opti-MEM
with 10% serum was added to each well before the plate was covered with an opaque
sticker, foiled, and analyzed. Imaging was done using a Cellomics ArrayScan VTI HCS
Reader (Thermo Fisher, Waltham, MA) and analysis was done using the included
software.
4.4 Results and Discussion
4.4.1 Polymer Synthesis
The PPLG polymers were prepared as previously described [11]. Briefly, y-propargyl L-
glutamate was reacted with triphosgene to form the NCA. PPLG and PEG-b-PPLG were
prepared by ring opening polymerization in dimethylformamide (DMF) at room
temperature by initiation with heptylamine and PEG-NH 2 (MW=5000), respectively.
Table 4.1 summarizes the stoichiometric feed ratio of each polymerization, the degree of
polymerization characterized by 1H-NMR, and the molecular weight and molecular
weight distribution characterized by gel permeation chromatography (GPC) with DMF as
the carrier solvent. The narrow polydispersities (1.09-1.25) and reaction feed ratio
compared to the degree of polymerization by 1H-NMR indicate that the polymerization is
well controlled. Furthermore, this polymerization route allows for high molecular weight
polymers with a degree of polymerization as high as 140. As indicated by Poche et al., a
high degree of polymerization can be obtained if the NCA monomer purity is high; the
washing strategy employed in this NCA monomer preparation does significantly improve
the monomer purity by removing residual HC1 [47].
DMF GPC with PMMA
Polymer Feed ratio DP by NMR Mn Mw PDI
PPLG 25 30 6100 7600 1.25
PPLG 50 56 12700 14100 1.11
PPLG 75 75 17900 19400 1.09
PPLG 150 140 42900 50000 1.17
PEG-NH 2  -- -- 10000 11500 1.14
PEG-b-PPLG 25 23 14600 15800 1.08
Table 4.1 Summary of PPLG Polymerization
Summary of polymerization feed NCA-monomer/initiator, degree of polymerization by -
'H-NMR, molecular weight and polydispersity determined by DMF GPC with PMMA
standards.
Six different amine moieties ranging in pKa (primary, secondary, and tertiary
amines) and hydrophobicity (dimethylethanamine, dimethyl-propanamine, diethylamine,
and diisopropylamine) were attached to four different molecular weight PPLG backbones
and a PEG-b-PPLG diblock copolymer through the copper-mediated 1,3 cycloaddition
between the alkynes on the PPLG backbone and the azide bearing amine groups, shown
in Scheme 4.1. The labels under each side group are used to refer to each polymer
bearing that side group. The PPLG was coupled with azido amines using
CuBr/PMDETA as a catalyst in DMF with a molar ratio of alkyne/azide/CuBr/PMDETA
equal to 1/1.2/0.1/0.1. After the reaction was complete, the polymer was purified by
dialysis against water acidified with HCl (pH < 4) to remove any unreacted amino azides
and the copper catalyst.
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Scheme 4.1 Functionalization of PPLG by the alkyne-azide cycloaddition click
reaction and the pH responsive side groups.
The polymer structures were confirmed using 'H-NMR. Representative 'H-NMR
of the diethylamine and diisopropylamine substituted PPLG compared to the 1H-NMR of
PPLG are shown in Figure 4.1. For all amine groups, the coupling efficiency was near
quantitative, as indicated by the disappearance of the PPLG alkyne peak (a, 3.4ppm) and
ester peak (b, 4.7ppm) and the appearance of a new ester peak (k, 5.2ppm) and the
triazole ring peak (m, 8.15ppm). Furthermore, the peak integration for all samples tested
were as expected for near quantitative substitution without hydrolysis of the ester group
on the polymer side chains.
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Figure 4.1 NMR Spectra of Functionalized PPLG
A) PPLG in d7 DMF, B) PPLG functionalized with diethylamine in D20, and C) 'H-
NMR of PPLG functionalized with diethylamine in D20. The PPLG backbone has a
degree of polymerization of 75.
4.4.2 Investigation of Polymer Buffering and Solubility
To investigate pH responsiveness and the buffering behavior of these polypeptide
systems, titrations were performed on all polymers. Polymers were dissolved in 125 mM
NaCl at 10 mM polypeptide-amine (molarity based on repeat unit), titrated with
increasing pH to a pH of 10-10.5 using 0.1 M NaOH, and subsequently titrated with
decreasing pH using 0.1 M HCL. After titrations were complete, representative samples
were freeze dried, dissolved in D20, and analyzed using IH-NMR. From the 'H-NMR,
the spectra were nearly identical to those obtained before titrations, indicating that
hydrolysis did not occur during the 2-3 hour titration process. Representative titrations
with increasing pH are shown in Figure 4.2, where Figure 4.2A consists of the
dimethylethanamine polymers at varying degrees of polymerization, and Figure 4.2B
consists of titrations of each polymer side functional group with a degree of
polymerization of NCA backbone of 75. All polymers appear to have strong buffering
capacity in the pH range of 5-7.4, which scales with the pH range of typical extracellular
tissue to late endosomal pH [35, 36]. The diisopropylamine polypeptide exhibits the
sharpest buffering transition at pH 5.25; the diethylamine polymer also buffers in this
range, but with a broader transition that has a midpoint at the slightly higher pH of
approximately 6.5. The primary and secondary amine functional polymers interestingly
exhibit similar broad buffering behavior beginning at pH 5.5 with a midpoint at 7.25.
One would typically expect buffering at higher pH for primary and secondary amines
(pKa approximately 9-11) [48, 49], although some buffering is observed in these
polymers from pH 8 to 10. Polyelectrolytes typically exhibit broad buffering behavior
and shifted pKa values due to segmental charge repulsion. For the dimethyl substituted
amines, the dimethylethanamine exhibits buffering behavior starting at the same pH as
the primary and secondary amines with a midpoint falling between 6.5 and 7.0. These
values are consistent with the series of polymers with ethylene linker groups to the
tetrazole ring; whereas, the dimethylpropanamine polymer exhibits buffering at higher
pHs. The additional carbon between the amine group and the triazole ring results in a
higher pKa for the dimethylpropanamine. This shift in pKa could be the result of the
amine group being further removed from the electron withdrawing triazole ring or from
the decreased crowding experienced by the amine group. All of the polymers exhibit a
small amount of buffering at the start of the titration curve, at pH 3-4; the buffering in
this region could be a result of the triazole ring generated during the click reaction;
triazoles exhibit pKa's of less than 3.0 [48, 50]. The polymer buffering appears to have
little dependence on polymer molecular weight, as indicated in Figure 4.2A.
0.012A 0.2-DP=30
0.01 -- DP=56
- DP=75
0.008 -- DP=140
0.006
0.004
0.002
0.
0 2 4 6 8 10 12
pH
B 0-014 
- Primary
0.012 --- Secondary
0.01 - Dimethyleth
- - Dimethylprop
2 0.008 --- Diethyl
0.006 - -Diisopropyl
0.004
0.002 -
0
0 2 4 6 8 10
pH
Figure 4.2 pH Buffering of PPLG Homopolymers
Titrations of polymers at a concentration of 10mM using 0.1 M sodium hydroxide. A)
PPLG polymers functionalized with dimethylethanamine with varying degrees of
polymerization, and B) PPLG polymers with a degree of polymerization of 75.
The primary, secondary, and dimethyl polypeptides remain water soluble over the
entire pH range; however, as the cationic diethylamine and diisopropylamine
functionalized polypeptides are titrated from acidic to basic conditions, the amines
become deprotonated. The resulting uncharged polypeptide is no longer soluble in water,
leading to precipitation of the polypeptide from aqueous solution. For the diethylamine
and diisopropylamine functionalized PPLG, polymer precipitation was observed at
various pH values depending on polymer molecular weight. To determine the pH where
precipitation occurs, turbidity measurements were performed on the diethylamine and
diisopropylamine functionalized PPLGs by monitoring polymer solution transmission at
550nm, shown in Figure 4.3. When the polymers begin to precipitate out of solution,
there is a sharp drop in transmission. For the diethylamine functionalized PPLG (Figure
4.3, solid lines), precipitation occurred between 6.80 and 7.45 depending on the degree of
polymerization and for the diisopropylamine functionalized PPLG (Figure 4.3, dashed
lines), precipitation occurred between 5.23 and 5.59. These values are consistent with
the titration data shown in Figure 4.2. In general we see the anticipated trend that
increased molecular weight leads to precipitation at lower pH values and higher degrees
of ionization of the polymer functional group. It is notable that the diethylamine series is
more sensitive to molecular weight than the diisopropylamine series, which seems to
approach a limiting minimum pH value for precipitation. This result may be due to the
greater hydrophobicity of the diisopropylamine group as opposed to the diethylamine,
which would lead to a lower degree of solubility of the amine side chain and a decreased
dependence on molecular weight.
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Figure 4.3 Solubility Variation with pH for Tertiary Amine Substituted PPLG
Transmission as a function of pH for all diethylamine and diisopropylamine
functionalized polymers. Diethylamine is abbreviated DE and diisopropylamine is
abbreviated DI.
The pH transition observed for both the diisopropylamine and diethylamine
functionalized polymers can be utilized for the design of a pH responsive drug carrier in
which the responsive PPLG block would be the interior, pH responsive block of a
micellar system. To determine if the precipitation pH could be tuned, a 50:50 mixture of
diethylamine and diisopropylamine side groups was attached to PPLG (DP=140) to
generate a random copolymer. As shown in Figure 4.3 (dotted-gray line), the copolymer
precipitation pH falls between the precipitation pH values observed for the diethylamine
and diisopropylamine substituted PPLG (DP=140), indicating that the pH responsiveness
of the amine substitute PPLG block can be fine tuned by changing the ratio of side
groups. One could also envision using this strategy to incorporate side groups that will
improve the loading of a specific drug or increase polymer-gene complexation efficiency.
The buffering and the precipitation behavior were found to be fully reversible, as
indicated by reverse titrations that were performed on all polymers. For the completely
water soluble primary, secondary, and dimethyl polymers, the reverse titration curve has
the same shape as the original titration with no signs of hysteresis. For tertiary amine
polymers that precipitated out of solution, hysteresis was often observed for the larger
degrees of polymerization, such that the pH value for which the polymers re-dissolved
was often lower than the value observed for precipitation. For the shortest degree of
polymerization (DP=30), the polymers returned to solution at nearly the same pH as
when the precipitation was initially observed (Figure 4.4).
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Figure 4.4 Solubility Hysteresis of Tertiary Amine PPLGs
Transmission as a function of increasing and decreasing pH for diethylamine and
diisopropylamine with DP=30.
4.4.3 Secondary Structure
Circular dichroism (CD) was used to probe the secondary structure of the various
polymers as a function of pH. Polymer dissolved at 1mg/mL was brought down to a pH
of 3, titrated to a pH higher than 10, and then immediately titrated back to a pH of 3. A
sample CD titration of a secondary amine polypeptide with DP=75 is shown in Figure
4.5. When initially brought down to a pH of 3, the sample adopts a mixture of a-helix
and random coil conformations, as indicated by the minimum at 222nm, which is
characteristic of an a-helix and the second, more negative minimum at 204nm, which is
indicative of a combination of a-helix and random coil. As the sample pH is increased,
the sample adopts an all a-helical structure at high pH values (pH > 6.36), as indicated by
the minimums at 208nm and 222nm [51]. When the pH is decreased stepwise back
down to acidic pH, this a-helical structure transitions back to a mixture of a-helix and
random coil. The a-helix to random coil transition correlates well with the pKa observed
in the polymer titrations. In summary, the a-helix structure appears to correlate with the
uncharged polymer backbone; as the backbone becomes charged, the helical structure
becomes reversibly disrupted and exhibits some random coil structure.
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Figure 4.5 Circular Dichroism Spectra of PPLG with varying pH
A) Increasing pH CD titrations and B) decreasing pH CD titrations for secondary amine,
DP=75
4.4.4 Functionalized PEG-b-PPLG Self-Assembly
The self assembly of PEG-b-PPLG functionalized with diethylamine and
diisopropylamine was studied as a function of pH. The critical micelle concentration
(CMC) was determined for PEG-b-PPLG in water and amine functionalized PEG-b-
PPLG in buffer solutions at pH 9 and pH 5.5. The CMC was determined by fluorometry
using a pyrene probe. A representative example of the diisopropylamine functionalized
PEG-b-PPLG is show in Figure 4.6. As shown in Figure 4.6A, there is a clear break in
the emission ratio indicating a CMC for the amine functionalized PEG-b-PPLG in pH 9
buffer. In pH 5.5 buffer, no break in emission ratio was observed for the functionalized
polymer, indicating that these macromolecules do not self-assemble at all at this acidic
pH, but remain completely soluble in water. The observed CMC values for all diblock
polymers tested (Table 4.2), are of the same order of magnitude of PEG-b-PBLA [21]
and are several orders of magnitude lower than Pluronic micelle CMC values [52]. To
further verify that the self-assembled structures were micelles, AFM was performed on
diethylamine and diisopropylamine substituted PEG-b-PPLG cast from a water solution
adjusted with 0.1 M NaOH to pH~9. Spherical micelles were observed for the amine
substituted PEG-b-PPLG; Figure 4.6B shows an AFM image of the diisopropylamine
functionalized diblock copolymer. The micelles are thus able to form at moderate to high
pH, but become completely destabilized at low pH, making them of interest for drug
release in which a pH triggered rapid disassembly of drug carrier can be designed to take
place within acidic compartments to release a drug.
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Figure 4.6 CMC Determination for PEG-b-PPLG
A) CMC determination by fluorometry using a pyrene probe for the diisopropylamine
substituted PEG-b-PPLG in pH 5.5 and 9 buffer and B) AFM images of diisopropylamine
substituted PEG-b-PPLG at pH 8.88. The AFM images are 2 by 2 pLm with a height
range from -30 jim to 30 pm.
Solvent CMC (mg/mL) CMC (M)
PEG-b-PPLG MQ water 3.75x10~4 3.74x10~
Diethylamine pH 9 buffer 1.11x102 7.49x10~
pH 5.5 buffer -- --
Diisopropylamine pH 9 buffer 1.05x 10- 7.38 x 108
pH 5.5 buffer -- --
Table 4.2 CMC values for PEG-b-PPLG
CMC values for PEG-b-PPLG in water and amine functionalized PEG-b-PPLG in pH 5
and pH 9 buffer
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4.4.5 Impact of pH on Side Chain Hydrolysis
The functional groups introduced along the PPLG backbone are esters that can undergo
hydrolysis under basic conditions, yielding the loss of the amino side group and the
introduction of the carboxylate anion, thus introducing negative charge to the
polyelectrolyte backbone. Slow or moderate changes in the polypeptide backbone may
be of interest for drug delivery, gene delivery, tissue engineering, and coating
applications [30, 42, 53, 54]. Specifically, for systemic use, positively charged polymers
such as poly(L-lysine) and poly(ethylene imine) often exhibit significant cytotoxicity
[41]. The introduction of a mechanism that eliminates the multivalent positive charge
and transforms the polymer into the benign and naturally occurring negatively charged
poly(y-glutamic acid), which enhances the long-term biocompatibility of these polymers
[40, 41].
To determine the side chain ester hydrolysis rate and the change in polymer
secondary structure, 1H-NMR and CD measurements were taken at various time points
and pH conditions. Polymer samples (PPLG DP=75 with secondary amine and PEG-b-
PPLG with diethylamine and diisopropylamine), were dissolved in various pH buffers to
a concentration of 0.5-1 mg/mL and left to hydrolyze at room temperature. From 'H-
NMR, the amount of ester hydrolyzed was determined by comparing the peak integration
of the triazole peak from the ester side chain (8.15 ppm) to the integration of a new
triazole peak from the alcohol side chain byproduct (8.07 ppm). When the polyamide
backbone, which maintains an a-helical structure when at equilibrium at all pH
conditions investigated (pH 7.4, 9, and 11), undergoes hydrolysis, a glutamic acid residue
101
is generated. Poly(y-glutamic acid), like poly(L-lysine), maintains an a-helix in the
uncharged state, and is a random coil in the charged state [55]; thus as hydrolysis occurs
at more basic conditions we observe the loss of the a-helical polymer structure. Circular
dichroism at 222 nm was observed to determine the change in secondary structure as a
function of time. At 222nm, a shift from a strong negative value towards a small positive
value is indicative of a secondary structure shift, in this case, a shift from an a-helix to a
random coil.
The results of the ester hydrolysis study are shown in Figure 4.7 and Figure 4.8.
Representative ester hydrolysis plots for PPLG (DP = 75) functionalized with secondary
amine and PEG-b-PPLG functionalized with diethyl and diisopropylamine are shown in
Figure 4.7A, B, and C respectively. In Figure 4.8, the CD value observed at 222 nm is
plotted at various pH values as a function of time for PPLG (DP = 75) functionalized
with secondary amine. For all polymers, the rate of ester hydrolysis was highest at pH 11
and was increasingly slower as the pH was decreased. For example, in all cases complete
hydrolysis was observed at pH 11 (at 2 days for the secondary amine and diethylamine
and 11 days for the diisopropylamine), but at pH 5.5 after 15 days, all samples were less
than 2% hydrolyzed. When comparing the ester side chain hydrolysis between polymers,
the rate of hydrolysis at pH 7.4, 9, and 11 was fastest for PPLG functionalized with
secondary amine and slowest for PEG-b-PPLG functionalized with diisopropylamine.
For the diblock polymers, the polypeptide is encapsulated as the inner core of a micelle,
and is partially protected from hydrolysis, thus greatly slowing the rate of hydrolysis.
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Figure 4.7 Ester Hydrolysis of Side Chains
A) Percentage of ester side chains hydrolyzed as a function of time for PPLG (DP=75)
functionalized with secondary amine, B) PEG-b-PPLG functionalized with diethylamine,
and C) PEG-b-PPLG functionalized with diisopropylamine.
When looking at the secondary structure of PPLG (DP=75) functionalized with
secondary amine (Figure 4.8), the polymer adopts a random coil after 1 day (24 hours) in
pH 11 buffer solution, at pH 9, the polymer gradually adopts a random coil over several
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days, and at pH 7.4 the polymer primarily maintains an a-helical structure for multiple
days. When compared to the 'H-NMR data, at pH 11, the ester side chains have
completely hydrolyzed in two days, leaving poly(y-glutamic acid) which is in a random
coil conformation. For pH 9, at day 4, the polymer is 50% hydrolyzed, and the polymer
structure is nearly all random coil. This observation indicates that not all the ester side
chains need to be hydrolyzed for the a-helix to be disrupted. Similar CD trends were
observed for all PPLG (DP=75) and PEG-b-PPLG polymers tested. In summary, we can
control the rate of ester degradation and the rate of a-helix disruption by changing the
side chain functionality.
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Figure 4.8 Secondary Structure of PPLG Mediated by Side Chain Hydrolysis
CD value observed at 222nm at various pH values as a function of time for PPLG
(DP=75) functionalized with secondary amine.
4.4.6 siRNA Complexation
Studies have been performed to determine if the amine functionalized homopolymers
could complex siRNA into protective polyplexes. Polymers were mixed with siRNA at
various PPLG polymer to siRNA charge ratios (N/P) ranging from 1:1 to 50:1 in either
sodium acetate buffer (pH 5.5) or PBS (pH 7.4). Ribogreen was used to determine the
complexation efficiency of each polymer at the various ratios, shown in Figure 4.9. As
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shown in Figure 4.9A and C, all amine functionalized PPLG homopolymers prevent dye
access to more than 90% of siRNA at charge ratios above 4:1 in sodium acetate.
Additionally PPLGs with primary amine substituents are able to completely complex
siRNA at a charge ratio that is two-fold lower, indicating the strength of primary amines
for complexation. At the higher pH of PBS (7.4), fewer amines are charged, particularly
in the case of the dimethylethanamine, diethylamine, and diisopropylamine substituents,
leading to looser complexes and greater dye access. This manifests itself both at low
polymer:siRNA ratios for all of the polymers, and most notably for the
dimethylethanamine, diethylamine, and diisopropylamine PPLGs (see Figure 4.9B and
D). While these tertiary amine substituents may be useful for stimulating endosomal
escape, copolymers with primary and tertiary amines are more likely to exhibit properties
that enable full encapsulation of siRNA and buffering effects in vivo
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Figure 4.9 Complexation of siRNA by PPLG Homopolymers
Percentage of uncomplexed siRNA as a function of siRNA:Polymer (N/P) ratio for each
amine substituted PPLG for degree of polymerization 140 (A,B) and 75 (C,D).
Polyplexes were formed in either sodium acetate buffer (A,C) or PBS (B,D). The DP140
diisopropylamine sample was insoluble in PBS.
Polyplexes can be disrupted by the addition of a competing polyanion, such as
heparin. In Figure 4.10A, PPLGs (DP = 140) with primary amine substituents were
complexed at low (5:1) and high (25:1) N/P ratios in either sodium acetate or PBS, along
with PEI and Lipofectamine 2000 as controls. As anticipated, relatively low levels of
heparin were required to dissociate PPLG complexes formed at N/P 5:1 as compared
with those complexes formed at the 25:1 N/P ratio. PPLG complexes formed in PBS
were more easily disrupted than those formed at low pH, most likely because those
formed at low pH contained more positively charged amines, and were thus more tightly
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complexed. Figure 4.1 OB demonstrates this concept with different amine substituents. In
the DP75 polymers (red), the tertiary amine in the dimethylpropanamine group forms a
looser polyplex and is disrupted more readily than the secondary and primary amines.
However, for DP140, the dimethylpropanamine polyplexes begin to dissociate with the
same amount of added heparin as the primary and secondary polyplexes, indicating that
molecular weight is also a factor in polyplex stability. Thus, the siRNA complexation
behavior of these systems is tunable, and can be altered through the introduction of
different buffering amine functionalities, molecular weight and pH conditions of
complexation.
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Figure 4.10 Heparin Dissociation of PPLG Polyplexes
A) Complexes were formed in pH 5.5 Sodium Acetate buffer (squares) or PBS (circles)
at two different polymer:siRNA ratios (N/P). B) PPLGs with primary (circle), secondary
(square), or dimethylpropanamine (triangle) substitutions were complexed in sodium
acetate buffer prior to dissociation with heparin.
4.4.7 Cytotoxicity of PPLG
Given that PPLG polymers are able to efficiently encapsulate siRNA at relevant N/P
ratios, evaluation of polyplex cytotoxicity and on-target knockdown followed. The MTT
assay was used to evaluate the metabolic activity of cells treated with various
PPLG/siRNA formulations. As shown in Figure 4.11, both homopolymers and block
copolymers were generally well tolerated by HeLa cells, with viabilities generally at or
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above 75% for all formulations tested. This is a first-pass screen for cytotoxicity,
however, and future assays could examine membrane integrity, mitochondrial membrane
potential, nuclear size, and other indicators of acute and delayed toxicity.
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Figure 4.11 Cytotoxicity of PPLG Polymers
Relative Viability of cells treated with (A) PPLG homopolymers and (B) PEG-b-PPLG
Block Copolymers as determined by the MTT assay
4.4.8 siRNA Knockdown of PPLG
Knockdown studies were carried out using a HeLa cell line stably expressing both firefly
and Renilla luciferase such that on-target suppression of firefly luciferase could be
normalized to any off-target effects on Renilla luciferase [43]. This knockdown assay can
be performed in high-throughput and is amenable to screening many different polymers,
formulations, and treatment conditions. Figure 4.12 demonstrates the lack of knockdown
mediated by both PPLG homopolymers and PEG-b-PPLG block copolymers. The lack of
knockdown by the pegylated block copolymers is not surprising, as pegylation has been
shown to inhibit uptake of cationic polyplexes, which would therefore limit their
capability for knockdown [56]. The homopolymers also demonstrated a lack of specific
knockdown, regardless of amine substituent at both a moderate dose (50 ng/well) and
high dose (150 ng/well) of siRNA. The latter dose was sufficient to suppress 75% of gene
expression when delivered with Lipofectamine 2000, but not with any of the PPLGs.
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Given that the efficient complexation of siRNA by PPLG has been established, uptake
and endosomal escape were investigated further to determine the cause of the poor
knockdown.
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Figure 4.12 Knockdown of PPLG Homopolymers and PEG-b-PPLG Block
Copolymers
Knockdown of firefly luciferase by polyplexes formed at the N/P ratios shown by PPLG
Homopolymers (A,C) and PEG-b-PPLG Block Copolymers (B,D). HeLa cells were
treated with 50 ng/well (A,B) or 150 ng/well (C,D).
4.4.9 Polyplex Uptake
Internalization of polyplexes was quantified by flow cytometry following incubation with
polyplexes containing fluorescently labeled siRNA. As shown in Figure 4.13, all PPLGs
with the exception of the highly hydrophobic diisopropylamine are internalized at least as
well as Lipofectamine 2000, which is able to mediate efficient knockdown under the
experimental conditions used. At N/P 5, internalization is inefficient as the complexes are
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likely somewhat loose in the cell culture medium (pH 7.4). However at N/P 25, tighter
complexes are formed, likely resulting in smaller sizes which are more easily
internalized. As anticipated from the complexation results previously, the more charged
primary and secondary amine polymers are able to generate the most uptake. Diblock
copolymers showed very poor uptake (data not shown), likely as a result of the
pegylation [56]. Figure 4.14 is a fluorescence microscopy image further demonstrating
the effective internalization by PPLG, in this case the diethylamine substituent. Though
tertiary amines such as diethylamine may have been expected to internalize poorly, they
should be advantageous for escaping the endosom. Given that tertiary amine-based PPLG
polyplexes formed at N/P of 25:1 are able to efficiently enter cells, the limiting barrier to
effective knockdown must then either be endosomal escape or inefficient
decomplexation.
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Figure 4.13 Uptake of PPLG Polyplexes
HeLa cells were treated with polyplexes formed using labeled siRNA and cell-associated
fluorescence was subsequently measured by flow cytometry.
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Figure 4.14 Fluorescent Micrograph of siRNA Internalization
Fluorescent microscope images showing cell uptake of fluorescently labeled siRNA with
A) uncomplexed siRNA and B) complexed siRNA with diethylamine PPLG (DP = 75).
4.4.10 Endosomal Escape of PPLG
Endosomal escape was probed using methods described in detail in Chapter 2 of this
thesis. Screening identified the diethyl-PPLG as the polymer most capable of causing
endosomal escape. Figure 4.15 shows the escape caused by diethyl-PPLG as a function of
total polymer concentration, as the majority of polymer is likely free in solution at an N/P
ratio of 25:1. The free polymer stimulates escape at a lower concentration than that of the
polyplex since the effective free polymer concentration is lower in the case of the
polyplex due to the siRNA-bound polymer. Critically, the concentration at which escape
is achieved with the best performing PPLG is greater than the concentration present in the
high-dose siRNA knockdown treatment (dashed line). This implicates endosomal escape
as the most relevant barrier to efficient knockdown, as there simply is not enough PPLG
present in the endosomes to cause escape. One reason for this could be the lack of charge
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density of the diethyl PPLG, which contains 6-7 fold more mass per tertiary amine than
branched PEI.
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Figure 4.15 Endosomal Escape of PPLG-Diethyl Homopolymer and Polyplex
The endosomal escape caused by free diethyl-PPLG or diethyl-PPLG polyplexes was
quantified using the calcein assay developed in Chapter 2. Free bPEI 25k is shown as a
positive control. The dashed line indicates the polymer concentration used for the
delivery of 150 ng/well siRNA.
4.5 Summary
We have developed a new library of pH responsive polypeptides based on the
combination of NCA polymerization and alkyne-azide cycloaddition click chemistry.
PPLG homopolymers and PEG-b-PPLG block copolymers were substituted with various
amine moieties that range in pKa and hydrophobicity, and can be tuned for specific
interactions and responsive behaviors. We have demonstrated that these new amine-
functionalized polypeptides change solubility, or self assemble into micelles for the case
of diblock polymers, with degree of ionization and adopt an a-helical structure at
biologically relevant pHs. PPLG homopolymers and block copolymers were able to
efficiently complex siRNA but were unable to achieve targeted knockdown. While
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cellular internalization was sufficient, the amount of total polymer delivered to the cell
was inadequate to cause endosomal escape.
4.6 References
1. Deming, T.J., Synthetic polypeptides for biomedical applications. Progress in
Polymer Science, 2007. 32(8-9): p. 858-875.
2. Deming, T.J., Polypeptide and polypeptide hybrid copolymer synthesis via NCA
polymerization, in Peptide Hybrid Polymers. 2006, Springer. p. 1-18.
3. Osada, K. and K. Kataoka, Drug and gene delivery based on supramolecular
assembly of PEG-polypeptide hybrid block copolymers, in Peptide Hybrid
Polymers. 2006, Springer: Berlin. p. 113-153.
4. Daly, W.H., D. Poche, and I.I. Negulescu, Poly(Gamma-Alkyl-Alpha, L-
Glutamate)s Derived from Long-Chain Paraffinic Alcohols. Progress in Polymer
Science, 1994. 19(1): p. 79-135.
5. Bromley, E.H.C., et al., Peptide and Protein Building Blocks for Synthetic
Biology: From Programming Biomolecules to Self-Organized Biomolecular
Systems. ACS Chemical Biology, 2008. 3(1): p. 38-50.
6. Conn, P.M., ed. Progress in Molecular Biology and Translational Science.
Molecular Biology of Protein Folding, Part A. Vol. 83, Part 1. 2008, Elsevier Inc.:
London.
7. Harada, A., S. Cammas, and K. Kataoka, Stabilized alpha-helix structure of
poly(L-lysine)-block-poly(ethylene glycol) in aqueous medium through
supramolecular assembly. Macromolecules, 1996. 29(19): p. 6183-6188.
8. Appel, P. and J.T. Yang, Helix-Coil Transition of Poly-L-Glutamic Acid and
Poly-L-Lysine in D20. Biochemistry, 1965. 4(7): p. 1244-1249.
9. Ciferri, A., D. Puett, and L. Rajagh, Potentiometric Titrations and Helix-Coil
Transition of Poly(L-Glutamic Acid) and Poly-L-Lysine in Aqueous Salt
Solutions. Biopolymers, 1968. 6(8): p. 1019-1036.
10. Zimm, B.H. and J.K. Bragg, Theory of the Phase Transition between Helix and
Random Coil in Polypeptide Chains. Journal of Chemical Physics, 1959. 31(2): p.
526-535.
11. Engler, A.C., H.I. Lee, and P.T. Hammond, Highly Efficient "Grafting onto" a
Polypeptide Backbone Using Click Chemistry. Angewandte Chemie-International
Edition, 2009. 48(49): p. 9334-9338.
12. Kolb, H.C., M.G. Finn, and K.B. Sharpless, Click chemistry: Diverse chemical
function from afew good reactions. Angewandte Chemie-International Edition,
2001. 40(11): p. 2004-2021.
13. Xiao, C., et al., Facile Synthesis of Glycopolypeptides by Combination of Ring-
Opening Polymerization of an Alkyne-Substituted N-carboxyanhydride and Click
"Glycosylation". Macromolecular Rapid Communications, 2010. 31(11): p. 991-
997.
14. Tang, H.Y. and D.H. Zhang, General Route toward Side-Chain-Functionalized
alpha-Helical Polypeptides. Biomacromolecules, 2010. 11(6): p. 1585-1592.
114
15. Sun, J. and H. Schlaad, Thiol-Ene Clickable Polypeptides. Macromolecules, 2010.
43(10): p. 4445-4448.
16. Huang, J., et al., Hydrolytically Stable Bioactive Synthetic Glycopeptide Homo-
and Copolymers by Combination of NCA Polymerization and Click Reaction.
Macromolecules, 2010. 43(14): p. 6050-6057.
17. Reshetnyak, Y.K., et al., Energetics ofpeptide (pHLIP) binding to and folding
across a lipid bilayer membrane. Proceedings of the National Academy of
Sciences of the United States of America, 2008. 105(40): p. 15340-15345.
18. Zoonens, M., Y.K. Reshetnyak, and D.M. Engelman, Bilayer interactions of
pHLIP, a peptide that can deliver drugs and target tumors. Biophysical Journal,
2008. 95(1): p. 225-235.
19. Reshetnyak, Y.K., et al., Translocation of molecules into cells by pH-dependent
insertion of a transmembrane helix. Proceedings of the National Academy of
Sciences of the United States of America, 2006. 103(17): p. 6460-6465.
20. Yokoyama, M., et al., Preparation of micelle-forming polymer-drug conjugates.
Bioconjugate Chemistry, 1992. 3(4): p. 295-301.
21. Kwon, G., et al., Micelles Based on Ab Block Copolymers of Poly(Ethylene
Oxide) and Poly(Beta-Benzyl L-Aspartate). Langmuir, 1993. 9(4): p. 945-949.
22. Katayose, S. and K. Kataoka, PEG-poly(lysine) block copolymer as a novel type
of synthetic gene vector with supramolecular structure. Advanced Biomaterials in
Biomedical Engineering and Drug Delivery Systems, 1996: p. 319-320.
23. Takae, S., et al., PEG-detachable polyplex micelles based on disulfide-linked
block catiomers as bioresponsive nonviral gene vectors. Journal of the American
Chemical Society, 2008. 130(18): p. 6001-6009.
24. Miyata, K., et al., PEG-based block catiomers possessing DNA anchoring and
endosomal escaping functions to form polyplex micelles with improved stability
and high transfection efficacy. Journal of Controlled Release, 2007. 122(3): p.
252-260.
25. Masago, K., et al., Gene delivery with biocompatible cationic polymer:
Pharmacogenomic analysis on cell bioactivity. Biomaterials, 2007. 28(34): p.
5169-5175.
26. Opanasopit, P., et al., Block copolymer design for camptothecin incorporation
into polymeric micelles for passive tumor targeting. Pharmaceutical Research,
2004. 21(11): p. 2001-2008.
27. Itaka, K., et al., Biodegradable polyamino acid-based polycations as safe and
effective gene carrier minimizing cumulative toxicity. Biomaterials, 2010. 31(13):
p. 3707-3714.
28. Dekie, L., et al., Poly-L-glutamic acid derivatives as vectors for gene therapy.
Journal of Controlled Release, 2000. 65(1-2): p. 187-202.
29. Dubruel, P., L. Dekie, and E. Schacht, Poly-L-glutamic acid derivatives as
multifunctional vectors for gene delivery. Part A. Synthesis and physicochemical
evaluation. Biomacromolecules, 2003. 4(5): p. 1168-1176.
30. Chen, S.F., Z.Q. Cao, and S.Y. Jiang, Ultra-low fouling peptide surfaces derived
from natural amino acids. Biomaterials, 2009. 30(29): p. 5892-5896.
115
31. Wan, Q., et al., A Potentially Valuable Advance in the Synthesis of Carbohydrate-
Based Anticancer Vaccines through Extended Cycloaddition Chemistry. The
Journal of Organic Chemistry, 2006. 71(21): p. 8244-8249.
32. Yang, C.Y., et al., Biocompatibility of amphiphilic diblock copolypeptide
hydrogels in the central nervous system. Biomaterials, 2009. 30(15): p. 288 1-
2898.
33. Pochan, D.J., et al., SANS and Cryo-TEM study of self-assembled diblock
copolypeptide hydrogels with rich nano- through microscale morphology.
Macromolecules, 2002. 35(14): p. 5358-5360.
34. Nowak, A.P., et al., Rapidly recovering hydrogel scaffolds from self-assembling
diblock copolypeptide amphiphiles. Nature, 2002. 417(6887): p. 424-428.
35. Vaupel, P., F. Kallinowski, and P. Okunieff, Blood-Flow, Oxygen and Nutrient
Supply, and Metabolic Microenvironment of Human-Tumors - a Review. Cancer
Research, 1989. 49(23): p. 6449-6465.
36. Mellman, I., The Importance of Being Acid-The Role ofAcidification in
Intracellular Membrane Traffic. Journal of Experimental Biology, 1992. 172: p.
39-45.
37. Sonawane, N.D., F.C. Szoka, and A.S. Verkman, Chloride accumulation and
swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes.
Journal of Biological Chemistry, 2003. 278(45): p. 44826-4483 1.
38. Whitehead, K.A., R. Langer, and D.G. Anderson, Knocking down barriers:
advances in siRNA delivery. Nat Rev Drug Discov, 2009. 8(2): p. 129-138.
39. Boeckle, S., et al., Purification ofpolyethylenimine polyplexes highlights the role
offree polycations in gene transfer. Journal of Gene Medicine, 2004. 6(10): p.
1102-1111.
40. Adams, M.L., A. Lavasanifar, and G.S. Kwon, Amphiphilic block copolymersfor
drug delivery. Journal of Pharmaceutical Sciences, 2003. 92(7): p. 1343-1355.
41. Lynn, D.M. and R. Langer, Degradable poly(beta-amino esters): Synthesis,
characterization, and self-assembly with plasmid DNA. Journal of the American
Chemical Society, 2000. 122(44): p. 10761-10768.
42. Veron, L., et al., New hydrolyzable pH-responsive cationic polymers for gene
delivery: A preliminary study. Macromolecular Bioscience, 2004. 4(4): p. 431-
444.
43. Akinc, A., et al., A combinatorial library of lipid-like materials for delivery of
RNAi therapeutics. Nat Biotech, 2008. 26(5): p. 561-569.
44. Schutte, E., T.J.R. Weakley, and D.R. Tyler, Radical cage effects in the
photochemical degradation ofpolymers: Effect of radical size and mass on the
cage recombination efficiency of radical cage pairs generated photochemically
from the (CpCH2CH2N(CH3)C(O)(CH2)(n)CH3)(2)MO2(CO)(6) (n = 3, 8, 18)
complexes. Journal of the American Chemical Society, 2003. 125(34): p. 10319-
10326.
45. Carboni, B., A. Benalil, and M. Vaultier, Aliphatic Amino Azides as Key Building-
Blocksfor Efficient Polyamine Syntheses. Journal of Organic Chemistry, 1993.
58(14): p. 3736-3741.
46. Kalyanasundaram, K. and J.K. Thomas, Environmental Effects on Vibronic Band
Intensities in Pyrene Monomer Fluorescence and Their Application in Studies of
116
Micellar Systems. Journal of the American Chemical Society, 1977. 99(7): p.
2039-2044.
47. Poche, D.S., M.J. Moore, and J.L. Bowles, An unconventional methodfor
purifying the N-carboxyanhydride derivatives of gamma-alkyl-L-glutamates.
Synthetic Communications, 1999. 29(5): p. 843-854.
48. Clayden, J., et al., Organic Chemistry, ed. J. Clayden. 2001, Oxford: Oxford
University Press. 1508.
49. Bhatia, S.R., S.F. Khattak, and S.C. Roberts, Polyelectrolytesfor cell
encapsulation. Current Opinion in Colloid & Interface Science, 2005. 10(1-2): p.
45-51.
50. Eicher, T., S. Hauptmann, and A. Speicher, The Chemistry ofHeterocycles. 2nd
ed. 2003, Weinheim: Wiley-VCH. 221.
51. Johnson, W.C., Protein Secondary Structure and Circular-Dichroism - a
Practical Guide. Proteins-Structure Function and Genetics, 1990. 7(3): p. 205-
214.
52. Alexandridis, P., J.F. Holzwarth, and T.A. Hatton, Micellization ofPoly(Ethylene
Oxide)-Poly(Propylene Oxide)-Poly(Ethylene Oxide) Triblock Copolymers in
Aqueous-Solutions - Thermodynamics of Copolymer Association.
Macromolecules, 1994. 27(9): p. 2414-2425.
53. Liu, X.H., J.T. Zhang, and D.M. Lynn, Ultrathin Multilayered Films that Promote
the Release of Two DNA Constructs with Separate and Distinct Release Profiles.
Advanced Materials, 2008. 20(21): p. 4148-4153.
54. Zhang, J.T. and D.M. Lynn, Ultrathin multilayered films assembled from
"Charge-Shifting" cationic polymers: Extended, long-term release ofplasmid
DNA from surfaces. Advanced Materials, 2007. 19(23): p. 4218-4223.
55. Myer, Y.P., The pH-Induced Helix-Coil Transition of Poly-L-lysine and Poly-L-
glutamic Acid and the 238-mu Dichroic Band Macromolecules, 1969. 2(6): p.
624-628.
56. Sung, S.-J., et al., Effect of Polyethylene Glycol on Gene Delivery of
Polyethylenimine. Biological & Pharmaceutical Bulletin, 2003. 26(4): p. 492-500.
117
Chapter 5. Summary and Future Work
5.1 Summary
Nucleic acid delivery has the potential to treat a wide array of medical conditions
more effectively than the current standard of care, but vectors of suitable efficiency have
not yet been established. This thesis sought to examine the efficacy and toxicity of
nonviral nucleic acid delivery vehicles with respect to the sequential cellular processes
needed for transfection. In order to facilitate the design of such vehicles, emphasis was
placed on understanding the relationship between polymer structure and the efficiency of
the polymer in overcoming the various cellular barriers to transfection.
In the first portion of the thesis, tools were developed to analyze the intracellular
fate of a targeted block copolymer previously developed in the Hammond and Langer
labs [1]. This PAMAM-PEG-peptide triblock copolymer system was shown the be eight-
fold more efficient than the standard commercially available branched PEI (bPEI) in the
presence of serum. Cell uptake was efficient and ligand-mediated, however endosomal
escape was only achieved in one-third of cells under optimized conditions. This
quantification of endosomal escape was made possible by a novel image-based high-
throughput assay developed as a part of this thesis, which can be applied to any material
system in which endosomal escape is an important parameter. Finally nuclear localization
and intracellular disassembly were both shown to be important obstacles that the
PAMAM-PEG system was inadequately addressing [2].
The second portion of this thesis sought to address these shortcomings by
developing a hyperbranched polyamine capable of controlled disassembly and enhanced
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endosomal escape. A modular synthesis conducive to the crosslinking of any polyamine
with any diacid was employed to generate a small library of crosslinked linear
polyethylenimines (xLPEIs). These polymers contained either a disulfide linkage, in
order to degrade in response to intracellular reducing conditions, or a non-degradable
linkage as a control. The xLPEIs showed excellent transfection efficiency compared to
Lipofectamine and bPEI 25k as well as reduced toxicity, agreeing well with literature
reports of similar polymers. These excellent properties are conventionally ascribed to the
intracellular degradation of the polyplex via the bioresponsive disulfide crosslinker,
however this work demonstrates the reduction to be inconsequential for this particular
system. Instead, the excess free polymer not incorporated in the polyplex is shown to
promote highly efficient endosomal escape with remarkably low membrane toxicity,
leading to the improved properties over bPEI. Taken together, this emphasizes that
further development of electrostatically assembled polyplexes must be analyzed for the
impact on the excess polymer.
Finally, the tools developed for the study of plasmid DNA delivery were applied
to the delivery of siRNA by a class of amine-functionalized synthetic polypeptides. A
library of PPLG and PEG-b-PPLG synthetic polypeptides were functionalized with
various amine functionalities to generate polymers capable of siRNA binding, cell
uptake, and endosomal escape. As anticipated, polymers containing amines with higher
pKa values formed tighter complexes and were taken up by cells more efficiently.
However, high-throughput endosomal escape studies demonstrated that the minimum
concentration of polymer needed to achieve efficient escape was well above that present
in high-dose siRNA transfection studies, resulting a lack of knockdown. This systematic
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analysis suggests that the low charge density of this library, which arises as a result of its
excellent molecular weight control and ease of functionalization, is likely responsible for
the poor siRNA delivery.
5.2 Future Work
The thesis developed assays, mechanistic insights, and several classes of bioresponsive
materials in which the influence of material structure on the various steps in nucleic acid
delivery was studied. While the PAMAM and polypeptide based systems have shown
limitations that have been discussed thoroughly in this thesis, several important questions
and directions for materials development involving the xLPEI will be discussed here.
5.2.1 Hybrid Branched-Linear xLPE systems
The xLPEI polymers investigated were shown to be remarkably efficient in promoting
endosomal escape with low membrane toxicity. However, xLPEIs form large, loosely
compacted polyplexes, which would likely aggregate in serum, allow degradation of the
plasmid DNA, and be ineffective in vivo. Therefore the development of a system in
which smaller, more stable polyplexes are formed would be desirable. To that end, the
development of crosslinked branched PEI (xBPEI), which contains primary amines,
could lead to a polyplex with better biophysical properties. A hybrid system which uses
xBPEI at low N/P ratios to form the polyplex and is then supplemented with xLPEI at a
high N/P ratio may be effective. In such a system, the majority of the xLPEI would
remain free in solution as its secondary and tertiary amines would not confer enough
charge density to displace the xBPEI. The more stable polyplex would still be able to
efficiently escape the endosome as the free xLPEI would provide endosome
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destabilization. Intracellular destabilization of the polyplex could be achieved using a
degradable crosslinker (disulfide, hydrolytic, enzymatic, etc.). Figure 5.1 shows
preliminary data on xBPEI polyplexes, demonstrating their ability to disassemble in
response to intracellular reducing conditions.
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Figure 5.1 Disulfide-Mediated Dissociation of xBPEI Polyplexes
(A) Polyplexes were formed at N/P 3 in PBS and subsequently treated with 100 mM
DTT, causing destabilization of disulfide linked polyplexes but not control polyplexes.
(B) Disulfide-linked xBPEI polyplexes were formed as in (A) and subjected to 10 mM
glutathione (GSH), mimicking intracellular reducing conditions.
Though the idea of a 2-component, polyplex/free polymer hybrid system may seem
unnecessarily complex, it is the reality in any electrostatically assembled polymer gene
carrier. In fact, Wagner, et. al. have shown that the free polymer is essential for
transfection in vivo, demonstrating that free polymer is in fact able to reach the same
cellular compartments as polyplexes in vivo [3], indicating that this hybrid approach
could be successful.
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5.2.2 Ligand-targeted xLPEI systems
The initial rationale for developing the crosslinked PEI system was to develop a material
which would be a substitute for the PAMAM block of the PAMAM-PEG-ligand block
copolymer delivery system. To that end, xLPEI (as well as xBPEI as discussed in 5.2.1)
should be functionalized with PEG and targeting ligands to create block copolymers
similar to those investigated in Chapter 2. These block copolymers would have the
benefit of serum stability conferred by the PEG as well as tissue specificity as a result of
the ligand. Such a system would be ideal to explore the impact of targeting ligand on the
free polymer versus the polyplex, determining the optimal efficiency of these systems in
the presence of serum, and quantifying the effect of the PEGylation on endosomal escape
and toxicity. While PEGylation may abrogate some of the nonspecific uptake of the
xLPEI, specific uptake via receptor-ligand interactions may effectively compensate.
Optimization of this system would be an ideal intermediate step prior to in vivo
experiments for a specific application.
5.2.3 In vivo Evaluation of xLPEl toxicity and efficacy
Of greatest interest with any gene carrier is its ability to transfect tissues of interest in
vivo. As presently designed, preliminary biocompatibility studies could be quite useful,
though as mentioned in 5.2.2, PEGylation and tissue targeting with a homing peptide may
yield the most effective in vivo vector. Preliminary studies with xLPEI/xBPEI will be
quite useful, as commercial bPEI has several important toxicities, though it is nonetheless
used frequently in animal studies [4]. xLPEI has been shown to be less cytotoxic than
commercial bPEI in vitro as a result of causing less membrane damage, however it
remains to be seen whether this means in vivo toxicities such as red blood cell
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aggregation can be avoided. As a substantial fraction of xLPEI would have to be present
free in solution, dose-limiting toxicities for this free polymer could be established prior to
the development of more sophisticated targeted block copolymers.
5.2.4 Nuclear targeting
Chapter 2 demonstrated that a limiting factor in the PAMAM-PEG-ligand gene carrier
system was nuclear import. While in vitro transfection can still occur in systems with
poor nuclear import since immortalized cell lines are continuously dividing, in vivo
transfection cannot rely on the cell cycle for nuclear import. As a result, polymers which
can specifically transport to the nucleus and then subsequently disassemble would be of
great interest to the field. Nuclear translocation is frequently improved by the addition of
a short peptide which is recognized and bound by the importin protein family and then
transported into the nucleus [5]. This nuclear localization sequence (NLS) has been
shown to increase transfection efficiency when appended to DNA in various
configurations [6]. While the entire polyplex would be unable to cross the nuclear pore
complex (NPC), attaching NLS to the polymer may allow for the polyplexes to be
trafficking near the nucleus, or for partially disassembled polyplexes (e.g. plasmid DNA
with some polymer still bound) to be internalized.
5.2.5 High-Throughput Synthesis of Crosslinked Polyamines
Many structure-function relationships in gene delivery have been derived through the
high-throughput screening of combinatorial libraries of different polymeric materials [7,
8]. These approaches have also led to the identification of some of the most efficient
materials to date. One of the strengths of the xLPEI synthesis shown is that it can in
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principle be applied to the crosslinking of any polyamine with any diacid, allowing the
generation of a library of crosslinked polyamines. Synthetically, this can be accomplished
either with a robotics system or simply in a 96-well format on the benchtop. Purification
can be handled by 96-well ultrafiltration membranes and the remaining product can be
stored in aqueous solution or lyophilized. The advantage to such a strategy is that not
only could materials be generated in high-throughput, but analysis of the DNA binding,
cell uptake, endosomal escape, and overall transfection efficiency could be accomplished
in a 96-well plate format as well. Bringing high-throughput combinatorial approaches to
this system could identify the most ideal crosslinking conditions and crosslinking
components, as well as revealing new structure-function relationships.
5.3 Conclusions
This thesis described the rational design and systematic study of bioresponsive polymers
for nucleic acid delivery. A central theme of the study was understanding how the
structure of the polymers impacted each of the intracellular steps of delivery, rather than
solely the end result. A powerful tool for efficiently quantifying endosomal escape was
developed and applied to each of the material systems described. This assay was used to
demonstrate that free polymer in solution, not the presence of a functional bioresponsive
domain (as previously thought), was responsible for the highly efficient and relatively
nontoxic DNA delivery of a promising class of crosslinked polyamines. The development
of efficient gene carriers has been underway for decades, and yet no FDA-approved
therapies exist. It is hoped that the tools, materials, and systemic analysis of structure-
function relationships in this thesis will enhance the process of discovery and
development of clinically relevant gene carriers.
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